P2 - Poster Session 2

Event Time:	Monday May 6, 2019 11:30 am to 6:30 pm
Topic(s):	Neuro Trauma, Critical Care, and Sports Neurology, General Neurology, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Global Health, Headache, Movement Disorders, MS and CNS Inflammatory Disease, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Pain and Palliative Care, Research Methodology, Education, and History
Director(s):
Description:
Completion Message:
CME Credits:	0
Core Competencies:

Program Speakers - Tentative
Start/End Time	Title	Faculty
Currently there are no events in the timeline.

Disclosures
Speaker	Disclosure

Abstract Presenters
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	001	Metformin Use and Stroke Risk in Hispanic and Non-Hispanic Diabetic Male Veterans	Disclosure: Dr. Vasquez has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	001	Impact of Fremanezumab on Response Rates, Acute Medication Use, and Disability in Patients With Episodic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication	Disclosure: Dr. Winner has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Amgen, Supernus, Teva, Novartis, Avanir, and Promius.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	001	Incidence and trends of Frontotemporal Disorders in Olmsted County: a population based study (1995-2010).	Disclosure: Dr. Turcano has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	001	Quantifying CSF Biomarkers of Neuronal Injury, Neuroinflammation and Synaptic Integrity in Antibody-Mediated Encephalitis	Disclosure: Dr. Day has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with DynaMed (EBSCO Health). Dr. Day holds stock and/or stock options in ANI Pharmaceuticals (a generic pharmaceutical company).
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	001	The Oldest Strokes in the Oldest State: Experience of Acute Stroke at Maine Medical Center	Disclosure: Dr. Stanley has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	001	A Prospective Study of Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Identifying Ultrasonographic Features for Diagnosis and Prognosis	Disclosure: Dr. Crump has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck Serono, Teva Pharma, Biogen.
Epilepsy: Women's Issues
Start Time	Pub.	Title	Presenter
11:30 AM	001	Discontinuation Rates for Hormonal Contraception on Enzyme Inducing versus Other Antiepileptic Drug Categories: Interim Analysis of the Epilepsy Birth Control Registry	Disclosure: Dr. Herzog has received research support from Lundbeck.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	001	Central Meningioma Necrosis after CAR T-Cell Therapy	Disclosure: Dr. Levin has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	001	Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch	Disclosure: Dr. Shawen has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	001	Enhancing Skills in Serious Illness Communication in Neurology Residents Using Simulation- A Pilot Study	Disclosure: Dr. Osgood has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	002	Intra-arterial tPA administration during Mechanical Thrombectomy is Associated with Increased Risk of Subarachnoid Hemorrhage	Disclosure: Dr. Saini has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	002	Reduction in the Severity of Headache in Patients With Chronic and Episodic Migraine With Fremanezumab Treatment	Disclosure: Dr. Ashina has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder BioPharmaceuticals, Allergan, Amgen, Alder, Eli Lilly, Novartis and Teva.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	002	Absence of Embarrassability Distinguishes Frontotemporal Dementia from Alzheimer's Disease and Healthy Controls	Disclosure: Dr. Yerokhin has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	002	Sensitivity of Cell Count and Protein in Cerebrospinal Fluid for the Diagnosis of Autoimmune Encephalitis	Disclosure: Dr. Hebert has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	002	Differences in Presenting Symptoms of Acute Stroke Among Young and Older Adults	Disclosure: Dr. Huggins has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	002	Serum Cytokines and Chemokines in Chronic Inflammatory Demyelinating Polyneuropathy Compared to Diabetic Neuropathy, Idiopathic Neuropathy and Other Inflammatory Neuropathies	Disclosure: Dr. Shije has nothing to disclose.
Epilepsy: Women's Issues
Start Time	Pub.	Title	Presenter
11:30 AM	002	Catamenial epilepsy: prevalence in a heterogenous cohort of women with epilepsy	Disclosure: Dr. Kelly has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	002	A Case of Extracranial Metastatic Spread of a PTCH1- and TP53-mutated, Cerebellar Desmoplastic/Nodular Medulloblastoma in a Patient with Li-Fraumeni Syndrome	Disclosure: Dr. Lim Fat has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	002	Continuous Monitoring of Orthostatic Hypotension and Instability Events in Parkinson Disease	Disclosure: Dr. Hadley has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Great Lakes NeuroTechnologies.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	002	The Implementation and Assessment of a Comprehensive Simulation-Based Curriculum in Treating Acute Neurological Emergencies at UC San Diego: Preliminary Results and Findings	Disclosure: Dr. Wu has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	003	“Sacral Vein Sign” on MRI with Typical Findings of Spinal Arteriovenous Fistula Suggests a Pelvic Arteriovenous Fistula with Retrograde Spinal Venous Drainage	Disclosure: Dr. Swarnkar, MD has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	003	Single Therapeutic and Supratherapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults	Disclosure: Dr. Jakate has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan plc. Dr. Jakate holds stock and/or stock options in Allergan plc.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	003	Hemispheric Asymmetry Contributing to Socioemotional Behavior in Frontotemporal Dementia	Disclosure: Dr. Parand has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	003	Autoimmune encephalitis in children: A case series from a tertiary care center	Disclosure: Dr. Rutatangwa has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	003	Do Older stroke patients with higher NIHSS scores have increased DTN time?	Disclosure: Dr. Kasatwar has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	003	Guillain- Barré Syndrome following Influenza Vaccination in the United States: A CDC/FDA Vaccine Adverse Event Reporting System Study, 1990-2016	Disclosure: Dr. Nolasco has nothing to disclose.
Epilepsy: Women's Issues
Start Time	Pub.	Title	Presenter
11:30 AM	003	Trends In The Anti-Epileptic Drug Usage During Pregnancy And Malformation Outcomes Over Two Decades In Kerala Registry Of Epilepsy And Pregnancy	Disclosure: Dr. Keni has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	003	Presentation of High Grade Glioma Resembling Like Acute Disseminated Encephalomyelitis	Disclosure: Dr. Shah has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	003	Continuous Objective Monitoring in Parkinson’s Disease: A description of over 25,000 Parkinson’s symptom scores across the world using the Personal KinetiGraph (PKG) wearable monitoring device	Disclosure: Dr. Lynch has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GKC. Dr. Lynch holds stock and/or stock options in GKC which sponsored research in which Dr. Lynch was involved as an investigator. Dr. Lynch holds stock and/or stock options in GKC. Dr. Lynch has received research support from GKC.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	003	Application of Non-Mydriatic Retinal Photography in the Outpatient Neurology Setting	Disclosure: Dr. Pyatka has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	004	Atypical presentation of Neurologic complications of Osler-Weber-Rendu Syndrome: A case series	Disclosure: Dr. Saleh Velez has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	004	ACT for Migraine: Effect of Acceptance and Commitment Therapy (ACT) for High Frequency Episodic Migraine without Aura: A phase-II, multicentric, randomized, open-label study	Disclosure: Dr. Grazzi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Inc. and ElectroCore, LLC.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	004	The Cognitive Aspects of Sexual Intimacy in Dementia Patients: A Neurophysiological Review and Insights for Diagnosis and Treatment	Disclosure: Dr. Nordvig has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	004	Determining the Prevalence of Sleep Disturbances in Autoimmune Encephalitis	Disclosure: Dr. Blattner has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	004	The relationship between individual risk factors and likelihood to list modifiable stroke risk factors amongst racial/ethnic minority seniors in Los Angeles	Disclosure: Dr. Urbano has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	004	Trends In Outpatient And Hospitalization Charges Relevant To the Management of Chronic Inflammatory Demyelinating Polyneuropathy: A Statewide Planning and Research Cooperative System (SPARCS) Study 2002-2014	Disclosure: Dr. Zhang has nothing to disclose.
Epilepsy: Women's Issues
Start Time	Pub.	Title	Presenter
11:30 AM	004	Is Pre-conceptional counselling for Women with Epilepsy (WWE) beneficial: Experience from Kerala Registry of Pregnancy and Epilepsy, India	Disclosure: Dr. BAISHYA has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	004	Leptomeningeal Carcinomatosis in a patient with Waldenstrom Macroglobulinemia.	Disclosure: Dr. Atta has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	004	Activity-independent detection of mediation states in individuals with Parkinson’s disease using wearable sensors	Disclosure: Dr. Hssayeni has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	004	Judgements of Competence: Negotiated Meaning Making in Resident Evaluations	Disclosure: Dr. Larsen has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	005	Cocaine- induced Vasospasm During Mechanical Thrombectomy in Acute Ischemic Stroke Patients: A Report of Two Cases	Disclosure: Dr. Kushnirsky has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	005	Pharmacokinetics, safety, and tolerability of DFN-02, an intranasal sumatriptan spray containing a permeation enhancer, compared with intranasal sumatriptan in healthy adults	Disclosure: Dr. Gautam has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Dr Reddy's Laboratories.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	005	Intrinsic amygdala connectivity as an endophenotype for social behavior: A novel SNP affecting CSMD1 increases amygdala connectivity and prosocial behavior in a GWAS meta-analysis.	Disclosure: Dr. Bickart has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	005	Autoimmune Encephalitis in the Neurologic Intensive Care Unit: Clinical Characteristics, Complications, and Outcomes.	Disclosure: Dr. Shah has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	005	Mechanical Thrombectomy is effective and safe on elderly stroke patients	Disclosure: Dr. Elnazeir has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	005	A Case Series of Patients with Neurofascin Associated Peripheral Neuropathies	Disclosure: Dr. Aziz-Donnelly has nothing to disclose.
Epilepsy: Women's Issues
Start Time	Pub.	Title	Presenter
11:30 AM	005	Increased Lamotrigine Clearance and Decreased Levels with Non-oral Hormonal Contraceptive Use	Disclosure: Dr. King has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	005	A Rare Case of Primary Neurolymphomatosis in Natural Killer T-Cell Lymphoma	Disclosure: Dr. Roberts has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	005	An Investigation of Tracking Technology in the Setting of an Established Exercise Program for Individuals with Parkinson’s Disease: A 10-Month Program	Disclosure: Dr. Ingersoll has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	005	Using Smartphone Mindfulness Apps to Increase Trainee Resilience and Reduce Burnout	Disclosure: Dr. Yeo has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	006	Artificial Intelligence in Acute Stroke Diagnostics: Application in Large Vessel Occlusions	Disclosure: Dr. Murray has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	006	Eptinezumab for Prevention of Chronic Migraine: Results of 2 Infusions in the Phase 3 PROMISE-2 (Prevention of Migraine via Intravenous Eptinezumab Safety and Efficacy?2) Trial	Disclosure: Advisory board: Amgen, Alder, Eli Lilly, Biohaven, Xoc; Speaking: Amgen, Teva Dr. Kudrow has received research support from Yes, I served as an investigator for Amgen, Alder, Eli Lilly, Teva, Biohaven, Roche-Genentech, Biogen, VM Biopharma
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	006	Phenotypic Complexity and the Likelihood of a Diagnostic Result in a Sequencing Test of 2,300+ Genes Associated with Autism Spectrum Disorders and/or Intellectual Disability	Disclosure: Dr. Brandt has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GeneDx.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	006	Clinical, radiological and laboratory comparison between autoantibody-negative and autoantibody-positive Autoimmune Encephalitis patients.	Disclosure: Dr. Giordano has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	006	Characteristics and Outcomes of Mechanical Thrombectomy in Nonagenarians	Disclosure: Dr. Mannava has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	006	Clinical and Electrophysiological Features of Chronic Inflammatory Demyelinating Polyneuropathy in Chile.	Disclosure: Dr. Cea Munoz has nothing to disclose.
Epilepsy: Women's Issues
Start Time	Pub.	Title	Presenter
11:30 AM	006	Adherence of Saudi women with epilepsy to folic acid intake in pre-conceptional period in Riyadh, Saudi Arabia.	Disclosure: Dr. Alqahtani has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	006	A protean case of neurolymphomatosis	Disclosure: Dr. Valentine has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	006	Wearable sensor (Parkinson’s Kinetigraph) and dopamine transporter imaging as potential biosignature for constipation in Parkinson’s	Disclosure: Dr. van Wamelen has received research support from Britannia Pharmaceuticals.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	006	Making Well Neurologists: A Multifaceted Program for Neurology Trainee and Faculty Wellbeing	Disclosure: Dr. Miller-Kuhlmann has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	007	Moyamoya Disease Associated with Autoimmune Hemolytic Anemia: A Case Report	Disclosure: Dr. Agarwal has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	007	Eptinezumab Meaningfully Improves Quality of Life (QoL) in Patients with Episodic or Chronic Migraine Within 1 Month After Treatment	Disclosure: Dr. Spierings has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen. Dr. Spierings has received research support from Amgen, Teva, Alder, AOBiome, Allergan, and Pfizer.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	007	Exploring functional connectivity correlates of problem solving under stress	Disclosure: Dr. Beversdorf has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Best%20Doctors%2C%20YAMO%20pharmaceuticals%2C%20Quadrant%20Biosciences, Stalicla,. Dr. Beversdorf has received personal compensation in an editorial capacity for Research in Autism Spectrum Disorders.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	007	Imaging and Pathologic Findings in an Adult and Pediatric Case of Anti-GABA-A Receptor Encephalitis	Disclosure: Dr. Cherayil has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	007	Clinical Outcomes following Endovascular Therapy and/or Thrombolysis in Elderly with Large Vessel Occlusion Strokes: A “Real World” Experience	Disclosure: Dr. Ranasinghe has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	007	Long Term Differential Outcomes of CIDP Patients After Using IVIG, Plasmapheresis, Or Corticosteroids: A Statewide Planning and Research Cooperative System (SPARCS) Study 2002-2014	Disclosure: Dr. Zhang has nothing to disclose.
Epilepsy: Women's Issues
Start Time	Pub.	Title	Presenter
11:30 AM	007	Malformation Risk Of Newer AEDs In Women With Epilepsy	Disclosure: Dr. Thomas has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	007	A rare case of Isolated Neurolymphomatosis of Multiple Cranial Nerves Palsy	Disclosure: Dr. Ho has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	007	The Feasibility of Using Smart Gloves to Quantify Hand Movements in Parkinson’s Disease	Disclosure: Dr. Abtahi has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	007	Real-Time Assessment of Residents’ Perceptions of Inappropriate Neurology Consults	Disclosure: Dr. Gentile has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	008	Diagnosis and Treatment of Steroid Responsive Cerebral Amyloid Angiopathy Related Inflammation without Brain Biopsy	Disclosure: Dr. Kaur has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	008	Reduction in the Number of Headache Hours in Chronic and Episodic Migraine With Fremanezumab	Disclosure: Dr. Cohen has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Teva Pharmaceuticals.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	008	Delirium Assessment for Acute Ischemic Stroke Patients at UNMC	Disclosure: Dr. Baang has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	008	NMDAR encephalitis associated with HIV "CNS escape"	Disclosure: Dr. Moloney has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	008	Not all Strokes in the Young are Vasculitis: A Challenging Case of Thrombotic Thrombocytopenic Purpura	Disclosure: Dr. Swavely has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	008	Vasculitic Peripheral Neuropathy, differences between Systemic and Non-Systemic etiologies.	Disclosure: Dr. Castiglione has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	008	STXBP1 is associated with bruxism in awake patients	Disclosure: Dr. Rezazadeh has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	008	Superficial Siderosis Associated with Central Neurocytoma	Disclosure: Dr. Lobbous has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	008	Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease	Disclosure: Dr. Gwinn has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	008	Childbearing and parenthood during residency and fellowship.	Disclosure: Dr. Irshad has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	009	A case of prosopagnosia with the retained ability to recognize caricatures	Disclosure: Dr. Cook has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	009	Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine	Disclosure: Dr. Ailani has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder, Amgen, Allergan, Electrocore, Eli Lilly and Company, Promius, Teva, Impel, Satsuma, Miller Communications, Avent, Alpha, Sites Consulting, Revance, and Biohaven Dr. Ailani has received personal compensation in an editorial capacity for Current Pain and Headache Reports and Unusual Headache Syndromes. Dr. Ailani has received research support from American Migraine Foundation ARMR, Biohaven, Allergan, and Eli Lilly and Company.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	009	Allopregnanolone improves neuropsychiatric symptoms in elderly men with Fragile X-associated tremor/ataxia syndrome (FXTAS): Results from an open label study	Disclosure: Dr. Trivedi has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	009	Improving Utilization of Neurological Autoantibody Testing at a Public Hospital: A Quality Improvement Project	Disclosure: Dr. Blackburn has received research support from Genentech.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	009	Hypercoagulable States in Young Adults with Ischemic Stroke in a Stroke Belt State	Disclosure: Dr. Durica has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	009	Acute Inflammatory Demyelinating Polyneuropathy following Pembrolizumab infusion	Disclosure: Dr. Venkatraman has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	009	Outcome of Genetic Testing for Patients with Epilepsy is Associated with Age of Seizure Onset, Presence of Other Neurological Features and Concurrent Testing of Parents	Disclosure: Dr. McKnight has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GeneDx.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	009	Successful Treatment of CNS Involvement in Cutaneous T-Cell Lymphoma Mycosis Fungoides	Disclosure: Dr. Nayak has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	009	Self-Reported and Objective Monitoring of Physical Activity in Parkinson Disease	Disclosure: Dr. Mantri has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	009	Brain Death Determination Skills Workshop for Neurology Residents	Disclosure: Dr. Patel has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	010	'At a Loss for Words’: POEMS syndrome complicated by Acute Ischemic Stroke	Disclosure: Dr. Jacob has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	010	One-Year Treatment with Galcanezumab in Patients with Chronic Migraine: Results from the Open-Label Phase of the REGAIN Study	Disclosure: Dr. Detke has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Employee of Eli Lilly and Company. Dr. Detke holds stock and/or stock options in Eli Lilly and Company which sponsored research in which Dr. Detke was involved as an investigator.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	010	Altered Brain Metabolism Associated With Functional Motor Disorder: Preliminary Results Of The HYCORE Study.	Disclosure: Dr. Conejero has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	010	Need for ICD Code for Suspected Autoimmune Encephalitis as Demonstrated by Retrospective Ten Year Analysis of Unspecified Autoimmune Encephalitis Treated with Immunoglobulin or Plasma Exchange	Disclosure: Dr. Mendez Gomez has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	010	Focal Cerebral Arteriopathy in Young Adult Stroke Patients	Disclosure: Dr. McKenna has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	010	Rituximab for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: A retrospective chart review	Disclosure: Dr. Varon has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	010	FRRS1L gene Homozygous Mutation (p.Gly246del) in Puerto Rican Families With Epileptic Encephalopathy and Dyskinetic Movements	Disclosure: Dr. Abdelmoumen has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	010	Intraventricular lipids: A clue to early diagnosis of asymptomatic spinal dural teratoma rupture	Disclosure: Dr. Vaddiparti has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	010	Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science	Disclosure: Dr. Stephenson has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	010	Brain Death Exam and Breaking the News; Simulation Based training for Neurology Residents; a need for Standardization	Disclosure: Dr. Niazi has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	011	How Adverse Events Are Collected and Reported: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan	Disclosure: Advisory board: Amgen, Alder, Eli Lilly, Biohaven, Xoc; Speaking: Amgen, Teva Dr. Kudrow has received research support from Yes, I served as an investigator for Amgen, Alder, Eli Lilly, Teva, Biohaven, Roche-Genentech, Biogen, VM Biopharma
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	011	Corticolimbic Fast-Tracking: Enhanced Multimodal Integration in Functional Neurological Disorder	Disclosure: Dr. Diez Palacio has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	011	What Does a Positive Neuronal Antibody Titer Mean?	Disclosure: Dr. Wang has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	011	Angiomatosis Cerebri	Disclosure: Dr. Purohit has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	011	Acute Immune Sensory Polyradiculopathy (AISP): A Challenging Diagnosis	Disclosure: Dr. Vazquez Do Campo has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	011	Genetic Characterization and Prognosis of Adult Patients with Lennox-Gastaut Syndrome: A Prospective Case-Series Study	Disclosure: Dr. De Santis has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	011	Multifocal Cerebral Infarction and Status Epilepticus as a Result of 3-bromopyruvate Toxicity for Treatment of Ocular Melanoma	Disclosure: Dr. Taylor has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	011	Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson's Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study	Disclosure: Dr. Schneider has received research support from Teva Pharmaceutical Industries Nuredis Inc. Biohaven Pharma Acadia Pharmaceuticals.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	011	Flipped Classrooms as a Learning Tool for Neurology Noon Conference Curriculum	Disclosure: Dr. Bauman has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	012	Improved Functionality, Pain Relief, and Satisfaction in Patients Treated With Ubrogepant vs Placebo: Results from 2 Single-Attack Phase 3 Studies, ACHIEVE I and II	Disclosure: Dr. Viswanathan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Inc. Dr. Viswanathan holds stock and/or stock options in Allergan, Inc., which sponsored research in which Dr. Viswanathan was involved as an investigator. Dr. Viswanathan holds stock and/or stock options in Allergan, Inc.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	012	Do Anxiety and Depression Levels Interfere with Cognitive Performance in Ecuadorian Multiple Sclerosis Patients? – a Case-Control Study	Disclosure: Dr. Barzola-Castro has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	012	Cerebral FDG-PET Findings in a Patient with Limbic Encephalitis: an Important Aid to Localize the Affected Region and Support the Diagnosis of Autoimmune Encephalitis.	Disclosure: Dr. Murray-Frank has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	012	Associations Between Risk Factors and Stroke Mechanisms in Young Adult Stroke	Disclosure: Dr. Michaels has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	012	The prevalence, severity and risk factors for chemotherapy induced peripheral neuropathy at 0 and 2 years after the completion of paclitaxel therapy	Disclosure: Dr. Kolb has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	012	Will You Get Stuck? Predicting Trafficking Deficient SCN1B Mutations from Localization and Amino Acid Change	Disclosure: Dr. Saban has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	012	An Uncommon Cause of Subcortical Low Intensity T2 Lesion	Disclosure: Dr. Caraballo-Cartagena has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	012	A Virtual Cohort Study of LRRK2 G2019S Carriers: A Novel Model for Long-Term Observation	Disclosure: Dr. Schneider has received research support from Teva Pharmaceutical Industries Nuredis Inc. Biohaven Pharma Acadia Pharmaceuticals.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	012	The Use of Standardized Patients versus Mannequin-Simulation for Training in Neurologic Emergencies – How “Real” is Real Enough? A Pilot Study	Disclosure: Dr. Albin has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	013	Quarterly Administration of Fremanezumab Does Not Show “Wearing Off” Effect During Third Month After Injection	Disclosure: Dr. Blaiss has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	013	Reflexia Alternans in the Setting of Electroconvulsive Therapy	Disclosure: Dr. Gates has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	013	Coexisting Anti-Ma and Anti-NMDA-R Antibody Syndromes in a Case of Brainstem and Limbic Encephalitis	Disclosure: Dr. Kammeyer has nothing to disclose.
Stroke in the Young and Elderly
Start Time	Pub.	Title	Presenter
11:30 AM	013	Impact of race in ischemic stroke affecting young adults	Disclosure: Dr. Hussein has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	013	Proximal Median Neuropathy with Brachial Plexitis After PICC Placement; a Case Study and Review of Neurologic Complications Associated with Central Venous Catheter Placement	Disclosure: Dr. Seligman has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	013	Seizures, dystonia and progressive cerebellar degeneration in homozygous DNAJC19 mutation without dilated cardiomyopathy or 3-methylglutaconic aciduria	Disclosure: Dr. Ruiz Lopez has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	013	Glioblastoma multiforme that present with radiographic dural tails. Questioning the prognosis paradigm with case-based evidence of greater than average length of survival	Disclosure: Dr. Michaelson has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	013	Can Art Therapy improve signs and symptoms of Parkinson's Disease? Preliminary Results from the "ExplorArtPD Study"	Disclosure: Dr. Cucca has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	013	A Medical Legal Curriculum for Residents to Increase Physician Comfort in Patient Interactions	Disclosure: Dr. Therkelsen has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	014	Safety from Phase 3 Clinical Studies Comparing Galcanezumab and Placebo in Patients with Episodic and Chronic Migraine	Disclosure: Dr. Bangs has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Bangs holds stock and/or stock options in Eli Lilly and Company.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	014	Impact of Antipsychotic Treatment Switching in Patients With Schizophrenia, Bipolar Disorder, And Major Depressive Disorder	Disclosure: Dr. Carroll has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceutical Industries Ltd.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	014	An unusual late presentation of anti-NMDA Receptor (NMDA-R) Autoimmune Encephalitis following Herpes Simplex Virus (HSV) Encephalitis	Disclosure: Dr. Ewida has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	014	Establishing Criteria for Triage of Primary Intracerebral Hemorrhage Patients: Optimizing ICH Care Across Health Care Systems	Disclosure: Dr. Alex has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	014	Inflammatory Ischemic Nerve Injury Can Cause CIDP-like Neuropathy	Disclosure: Dr. Thaisetthawatkul has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	014	Progressive Myoclonus Epilepsy of Lafora First Diagnosed in El Salvador	Disclosure: Dr. Silva has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	014	Isolated CNS Blastic Plasmacytoid Dendritic Cell Neoplasm in a Patient with AML	Disclosure: Dr. Metrus has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	014	Effect of Balanced Based Torso Weighting on Gait in Parkinsonism.	Disclosure: Dr. Safarpour has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbvie.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	014	The Impact of a Dedicated Emergency Department Neurology Resident on the Inpatient Neurology Service	Disclosure: Dr. Sheikh has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	015	Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients With Chronic Migraine: Results of a 1-Year Study	Disclosure: Dr. McAllister has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen Inc., Teva Neuroscience, Alder, Promius, Electrocore, and Allergen, Inc. Dr. McAllister has received personal compensation in an editorial capacity for Practical Neurology. Dr. McAllister has received research support from Alder, Amgen Inc., Teva Neuroscience, Sunovion, San-bio, Biohaven, Allergan, Inc., Novartis, ATI, Roche Diagnostics Corporation, Esai Inc., and Biogen Idec.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	015	Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-831, a Selective D-amino Acid Oxidase Inhibitor, in Healthy Volunteers	Disclosure: Dr. Xu has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Takeda Pharmaceuticals International, Inc.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	015	Anti-N-Methyl-D-Aspartate (NMDA) Encephalitis Associated with Tall-cell Variant Papillary Thyroid Carcinoma	Disclosure: Dr. Mahadeen has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	015	Outcomes in Transferred Stroke Patients with Large Vessel Occlusion (LVO) after IV rt-PA	Disclosure: Dr. Swamy has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	015	Acute Motor And Sensory Axonal Neuropathy following Diarrheal Illness with Concomitant Dry Beri Beri following Bariatric Surgery	Disclosure: Dr. Ghonim has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	015	Differential Methylation Profiles of BDNF Promoters I and IV in Patients with Temporal Lobe Epilepsy	Disclosure: Dr. Secchi has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	015	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) manifesting in the Course of Treatment of Hodgkin’s Lymphoma with Brentuximab	Disclosure: Dr. Frey has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	015	KICK-OUT PD: Mobility, Quality of Life, and Feasibility Outcomes in a Pilot Study of a PD-Specific Karate Intervention	Disclosure: Dr. Sennott has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	015	Enhancing Neurology Resident Education Utilizing Prehospital Stroke Telemedicine to Shorten Time to Acute Stroke Intervention	Disclosure: Dr. Tipton has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	016	OnabotulinumtoxinA Is Safe and Effective in Patients Who Discontinue Topiramate: Results of the FORWARD Study	Disclosure: Dr. Rothrock has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Amgen, Lilly, and Supernus. Dr. Rothrock has received research support from Allergan plc, Amgen, and Dr. Reddy’s Laboratories.
Behavioral Issues
Start Time	Pub.	Title	Presenter
11:30 AM	016	Individual Differences in Social Network Size Linked to Nucleus Accumbens and Hippocampal Volumes in Motor Functional Neurological Disorders	Disclosure: Dr. Ospina has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	016	When Autoimmune Encephalitis masquerades as an Eating Disorder, two case reports on unique presentation of anti - NMDAR Encephalitis.	Disclosure: Dr. Virupakshaiah has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	016	Interfacility Transfer for Mechanical Thrombectomy – Direct to Neuroangiography or CT Angiography First?	Disclosure: Dr. Humbert has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	016	Nivolumab induced neurological syndrome mimicking acute inflammatory demyelinating polyneuroradiculopathy responding to infliximab	Disclosure: Dr. Kairamkonda has nothing to disclose.
Epilepsy: Genetics
Start Time	Pub.	Title	Presenter
11:30 AM	016	Adenosine Deaminase (ADA1) Gene Variants are Associated with Mood Disorders in Patients with Temporal Lobe Epilepsy	Disclosure: Dr. Secchi has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	016	Pilocytic Astrocytoma in an Elderly Patient with Eleven Years of Follow-up: A Case Report and Commentary on Management of PA in An Elderly Patient	Disclosure: Dr. Cofer has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	016	Medical Cannabis in the Treatment of Parkinson’s Disease	Disclosure: Dr. Myers has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	016	Advocacy education in neurology residency: A survey of U.S. neurology residency program directors	Disclosure: Dr. Stavros has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	017	Cardiovascular Profile of Dihydroergotamine Mesylate (DHE) Delivered by the POD® Device Compared to D.H.E. 45® for Injection from the INP104-101 Clinical Trial	Disclosure: Dr. Craig has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Impel NeuroPharma.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	017	Event Related Potentials as a possible Traumatic Brain Injury (TBI) biomarker in older patients at risk of neurodegenerative disorders	Disclosure: Dr. Turk has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	017	A case of CSF NMDA antibody negative NMDA encephalitis!	Disclosure: Dr. Abdalla has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	017	Transfer to Nearest Primary Stroke Center Portends Significant Delays and Poorer Outcomes in LVOs.	Disclosure: Dr. Arango has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	017	Multifocal motor neuropathy: a rare and complex disease - an university center’s experience.	Disclosure: Dr. Medeiros has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	017	The Risk of Seizure Recurrence in Patients with Status Epilepticus Requiring Anesthetic Treatment	Disclosure: Dr. Parsons has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	017	Glioblastoma and Disseminated Intravascular Coagulation: Literature Review and Illustrative Case	Disclosure: Dr. Akinduro has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	017	KICK-OUT PD: Qualitative Analysis of Expectations and Outcomes in a Pilot Study of a Parkinson’s Disease Karate Intervention	Disclosure: Dr. Fleisher has received research support from Biogen.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	017	Outcomes of a “Boot Camp” for incoming neurology residents	Disclosure: Dr. Valentine has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	018	Early and Sustained Effect of OnabotulinumtoxinA for Chronic Migraine Treatment: Pooled Analysis of PREEMPT Data	Disclosure: Dr. Manack Adams has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Aubrey Manack Adams, and Allergan plc. Dr. Manack Adams holds stock and/or stock options in Aubrey Manack Adams, and Allergan plc which sponsored research in which Dr. Manack Adams was involved as an investigator. Dr. Manack Adams holds stock and/or stock options in Aubrey Manack Adams, and Allergan plc.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	018	“Paroxysmal Symptoms and Correlated EEG findings in Dementia with Lewy Bodies”	Disclosure: Dr. Nandanwar has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	018	Diffuse White Matter Disease and Rapidly Progressive Dementia Secondary to Non-Paraneoplastic Voltage-Gated Calcium Channels Antibody	Disclosure: Dr. Landman has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	018	Gender Disparities in Misdiagnosis of Ischemic Stroke or TIA During Telestroke Consultation	Disclosure: Dr. Von Kleist has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	018	Guillain Barre Syndrome Variant with Facial Diplegia and Paresthesias presenting with Bulbar Weakness	Disclosure: Dr. Trikamji has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	018	Outcomes of Status Epilepticus in Elderly: a systematic review.	Disclosure: Dr. Sadeghi has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	018	To Biopsy or Not to Biopsy? A case of primary intramedullary spinal cord lymphoma presenting as longitudinally extensive transverse myelitis within cervical cord	Disclosure: Dr. Satyanarayan has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	018	The effect of metronome and music on gait variability in people with Parkinson’s disease	Disclosure: Dr. Hellman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	018	An Interactive, Video-Based, Online Curriculum in Movement Disorders for Neurology Housestaff: A Pilot Study	Disclosure: Dr. Vadlamani has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	019	A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Crossover Study Evaluating DFN-15, a Liquid Celecoxib Formulation, for the Acute Treatment of Migraine with or without Aura in Adults	Disclosure: Dr. Bennett has nothing to disclose.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	019	The Role of Neuroimaging in a Fragile X Carrier with only Dementia and Perypheral Neuropathy	Disclosure: Dr. Guimarães de Queiroz has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	019	A challenging case of intractable seizures in a pediatric patient with anti-GAD65 encephalitis	Disclosure: Dr. Kairamkonda has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	019	Complicated Migraines treated with Thrombolysis as an Ischemic Stroke mimic via Telestroke	Disclosure: Dr. Cash has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	019	Clinical and Epidemiological Profile of a Brazilian’s cohort of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy	Disclosure: Dr. Carvalho has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	019	Clinical Features and Outcomes of Patients with Status Epilepticus Caused by Neuroinflammation	Disclosure: Dr. Hara has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	019	Unusual case of recurrent SMART (stroke-like migraine attacks after radiation therapy) syndrome	Ninad Desai Disclosure: Dr. Patel has nothing to disclose.
Parkinson's Disease: Clinical Trials, Wearables, and Non-Pharmacologic Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	019	Determining the Efficacy of a Vibration Induced Intervention on Improving Arm Swing and Subsequent Gait Stability in Parkinsonian Patients	Disclosure: Dr. Taber has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	019	Burnout Rate Among Iraqi Neurology Residents	Disclosure: Dr. Al-Janabi has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	020	Early Migraine Response by Month 1 and Clinically Meaningful Improvements in Health-Related Quality of Life (HRQoL) in Patients with Migraine in Phase 3 Trials of Eptinezumab	Disclosure: Dr. Tepper has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Alder, Alexsa, Allergan, Alphasights, Amgen, Aperture Venture Partners, Aralez Pharmaceuticals Canada, Axsome Therapeutics, BioDelivery Sciences International, Biohaven, Charleston Labs, Decision Resources, DeepBench, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeura, Equinox, ExpertConnect, GLG, GSK, Guidepoint Global, Impel, M3 Global Research, Magellan Rx Management, Marcia Berenson Connected Research and Consulting, Medicxi, Navigant Consulting, Neurolief, Nordic BioTech, Novartis, Pfizer, Reckner Healthcare, Relevale, Satsuma, Scion Neurostim, Slingshot Insights, Sorrento, Spherix Global Insights, Sudler and Hennessey, Teva, Theranica, Thought Leader Select, Trinity Partners, XOC, and Zosano. Dr. Tepper has received personal compensation in an editorial capacity for American Headache Society. Dr. Tepper has received research support from Alder, Allergan, Amgen, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeura, Neurolief, Novartis, Teva, and Zosano.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	020	Primary Familial Brain Calcification	Disclosure: Dr. Radaideh has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	020	Anti-GAD Antibody Associated Encephalitis: A Child with Epilepsia Partialis Continua and Ataxia	Disclosure: Dr. Molinero has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	020	Telestroke Technology Decreases Time to Neurologist Evaluation for Emergent Stroke Treatment During After Hours	Disclosure: Dr. Zhang has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	020	Severe Subacute Motor Neuronopathy Associated with Non-Hodgkin B Cell Lymphoma	Disclosure: Dr. Khezri has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	020	Quantitative EEG Burst Suppression Ratio and Patient Outcome in Refractory Status Epilepticus	Disclosure: Dr. Mehdiratta has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	020	An Unusual Cause of Longitudinal Extensive Transverse Myelitis (LETM) in an Anti-Aquaporin-4 Antibody Positive Case	Disclosure: Dr. Yang has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	020	Clinical Experience in Over 100 Using Pimavanserin for Parkinson’s Disease Psychosis	Disclosure: Dr. Harsh has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	020	Effect on the Clinical Learning Environment after Expansion of the Thrombectomy Time Window	Disclosure: Dr. Aradine has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	021	Effect of Age on Efficacy and Safety of Galcanezumab Treatment in Adult Patients with Migraine	Disclosure: Dr. Stauffer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Employee of Eli Lilly and Company. Dr. Stauffer holds stock and/or stock options in Eli Lilly and Company as minor stockholder.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	021	The Cognitive Phenotyping of McCune-Albright Syndrome: A Case Series	Disclosure: Dr. Ham has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	021	Anti-GAD65 Antibody: a Possible Link to Encephalopathy, Aphasia, Seizures and Lateralized Weakness	Disclosure: Dr. Tantillo has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	021	Telestroke Sub-events and their Contribution to Door-to-Needle Time in a Telestroke Network	Disclosure: Dr. Rahangdale has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	021	Miller Fischer Syndrome after Vaccination in the United States: A CDC/FDA Vaccine Adverse Event Reporting System Study, 1999-2017	Disclosure: Dr. Hilmi has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	021	Benefits of Extended Targeted Temperature Management (TTM) in the Management of Super-Refractory Status Epilepticus Secondary to anti-NMDAR encephalitis	Disclosure: Dr. Ahmed has nothing to disclose.
The Power of Case Reporting in Neuro-Oncology I
Start Time	Pub.	Title	Presenter
11:30 AM	021	Atypical radiographic appearance of anaplastic ependymoma that mimics arteriovenous malformation: a case report	Disclosure: Dr. Hsieh has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	021	Physical Activity and Rates of Cognitive Decline in Early Parkinson Disease	Disclosure: Dr. Mantri has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	021	The?Impact of?a 24-hour?Thrombectomy?Window on Resident Education	Disclosure: Dr. Aubert has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	022	Precision Olfactory Delivery (POD®) of Drugs for Neurological Disease: A Safety, Tolerability and Comparative Bioavailability Study of POD Dihydroergotamine Mesylate (INP104) to Approved IV D.H.E. 45® and Migranal® Nasal Spray.	Disclosure: Dr. Shrewsbury has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Impel NeuroPharma.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	022	Compound heterozygous C9ORF72 hexanucleotide repeat expansions causing FTD	Disclosure: Dr. Anderson has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	022	Drug-Resistant Status Epilepticus Associated with GAD-65 Autoimmune Limbic Encephalitis	Disclosure: Dr. Shafqat has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	022	Implementation of Secure Messaging System Reduces Response to Page in Telestroke Network	Disclosure: Dr. Hackett has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	022	Different Effects of Selective Phosphodiesterase Inhibitors on Experimental Autoimmune Neuritis.	Disclosure: Dr. Fujioka has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Otsuka Pharmaceutical Co. Ltd., Biogen Japan, Novartis, Eisai, Daiichi-Sankyo.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	022	Cefepime-induced Non-convulsive Status Epilepticus	Disclosure: Dr. Hollen has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	022	Small RNA Deep Sequencing Identifies Unique Extracellular-derived Bioactive Noncoding RNA Cargos in Pediatric Brain Tumors	Disclosure: Dr. Magana has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	022	The Effect of High-Intensity Exercise on Objective Sleep Outcomes in Parkinson’s Disease	Disclosure: Dr. Amara has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Jazz Pharmaceuticals and Grey Matter Technologies. Dr. Amara has received research support from Parkinson's Disease Foundation and serves as site investigator for studies sponsored by the Michael J. Fox Foundation for Parkinson's Research, Abbvie, Axovant Neurological Solutions, and Jazz Pharmaceuticals.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	022	Improving Neurology Resident Well-Being Through Appreciative Inquiry: Results of a Pilot Session	Disclosure: Dr. Dewey has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	023	Long-Term Impact of Fremanezumab on Headache-Related Disability, Quality of Life, and Patient Satisfaction in Episodic Migraine and Chronic Migraine	Disclosure: Dr. Cohen has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Teva Pharmaceuticals.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	023	A Novel PRNP-G131R Mutation Associated with Familial Prion Disease	Disclosure: Dr. Alshaikh has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	023	GAD 65 Antibody Encephalitis Presenting as New Onset Refractory Status Epilepticus (NORSE)	Disclosure: Dr. Sanei Moghaddam has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	023	Differences in Door-to-Needle Times and Functional Outcomes between Primary Stroke Centers and Non-Primary Stroke Centers in a Telestroke Network Among Patients Receiving Intravenous Tissue Plasminogen Activator	Disclosure: Dr. Ajinkya has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	023	Acute Motor-Sensory Axonal Variant of GBS with Cranial Nerve Involvement (Dysphagia) in a Patient with Acute Cervical Myelopathy Masking Upper Motor Neuron Signs	Disclosure: Dr. Argudo Luzuriaga has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	023	Implementation of Seizure and Status Epilepticus Protocols in the Emergency Department of a large Academic Hospital	Disclosure: Dr. Schreiber has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	023	Combined Pharmacologic Inhibition of MEK-ERK and PI3K/mTOR Signaling in Glioblastoma Models Enhances Therapeutic Antitumor Activity	Disclosure: Dr. Schreck has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	023	Transcranial Direct Current Stimulation for Limb-Kinetic Apraxia in Parkinson's Disease – a Randomized, Double-blinded, Sham-controlled Trial	Disclosure: Dr. Park has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	023	Medicolegal Considerations Influence Neurology Residents’ Perception of Inappropriate Consults	Disclosure: Dr. Loebel has nothing to disclose.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	024	Multiple, Once-Daily, Oral Doses of 150 mg Ubrogepant Administered for 28 Days Are Generally Well Tolerated, With No Clinically Significant Elevation of Alanine Aminotransferase in Healthy Adult Males	Disclosure: Dr. Ankrom has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck & Co, Inc.. Dr. Ankrom holds stock and/or stock options in Merck & Co, Inc., which sponsored research in which Dr. Ankrom was involved as an investigator.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	024	CSF1R Mutation-negative Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): Genotypic Heterogeneity in an Important Cause of Early-onset Dementia	Disclosure: Dr. Trewin has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	024	Evaluation of the Malignancy Risk Associated With Paraneoplastic Antibodies	Disclosure: Dr. Marquardt has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	024	Extending Telestroke Call Window to 24 Hours Increases Call Volume and Acute Stroke Treatments	Disclosure: Dr. Hackett has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	024	Is Alcoholic Neuropathy Selective ?	Disclosure: Dr. Visvanathan has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	024	Increased Risk of Status Epilepticus in Post-stroke Epilepsy Patients on Coumadin	Disclosure: Dr. Stepien has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	024	Inflammatory signaling supports cancer cell growth within the leptomeninges	Disclosure: Dr. Boire has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Arix Bioscience.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	024	How Parkinson’s Disease Affects Value-Based Decisions	Disclosure: Dr. Montaser-Khousari has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	024	Resident Tele-education using the Zeriscope Device	Disclosure: Dr. Milano has received research support from Biogen and Roche: Alzheimer's disease clinical trials.
Headache Clinical Trials II
Start Time	Pub.	Title	Presenter
11:30 AM	025	Efficacy of Erenumab in Chronic Migraine Patients With and Without Allodynia	Disclosure: Dr. Chou has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen, Inc. Dr. Chou holds stock and/or stock options in Amgen, Inc.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	025	Distinctive Clinical Features of Cerebral Amyloid Angiopathy Related Inflammation: the Vanderbilt University Medical Center Experience	Disclosure: Dr. Eaton has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	025	An Atypical Presentation of Anti-Hu Receptor Meningoencephalitis	Disclosure: Dr. Heckel has nothing to disclose.
Telestroke and Transfer Process
Start Time	Pub.	Title	Presenter
11:30 AM	025	C3FIT (Coordinated, Collaborative, Comprehensive, Family-Based, Integrated, and Technology-Enabled Care): A Randomized Controlled Comparative Effectiveness Trial on Stroke Health Care Delivery.	Disclosure: Dr. Gopal has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	025	2 cases of hypertrophic CIDP associated to other autoimmune neurological disorders: Myasthenia Gravis and Multiple Sclerosis.	Disclosure: Dr. Mantelatto Bonsi has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	025	Pharmacological treatment of status epilepticus at UNMC: assessment of seizure outcomes	Disclosure: Dr. Baang has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	025	Selective Activation of PIK3CB in Glioblastoma Multiforme	Disclosure: Dr. Winn has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	025	Suicidal Behavior in Parkinson Disease	Disclosure: Dr. Koo has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	025	Assessment of Resident Opinions and Knowledge of Neurology Subspecialty Fellowship Application	Disclosure: Dr. Ahmad has nothing to disclose.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	026	Morphometric correlation of parkinsonian signs in different primary progressive aphasia syndromes	Disclosure: Dr. Couto has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	026	Post-Herpes Autoimmune Encephalitis	Disclosure: Dr. Mrad has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	026	Intra-arterial mesenchymal stem cell therapy modulates inflammasome to confer neuroprotection in animal model of ischemic stroke	Disclosure: Dr. Bhattacharya has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	026	Safety of Therapeutic Plasma Exchange for the Treatment of Guillain-Barré Syndrome in Polycythemia Vera	Disclosure: Dr. Abrams has nothing to disclose.
Epilepsy: Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	026	Cessation of Intrathecal Tranexamic Acid Induced Status Epilepticus with Pentobarbital	Disclosure: Dr. Prior has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	026	Stearoyl CoA Desaturase is an essential regulator of fatty-acid-induced ER stress and a therapeutic target in gliomablastoma	Disclosure: Dr. Hashemiaghdam has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	026	Alzheimer’s Disease Genetic Risk Variants Predict Cognitive Decline in Parkinson’s Disease	Disclosure: Dr. Baratta has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	026	The Past, Present, and Future of the Clinical Neurophysiology Fellowship: A Survey of Program Directors	Disclosure: Dr. Colletta has nothing to disclose.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	027	Saccadic Eye Movements: A Glimpse into Cognitive Impairment	Disclosure: Dr. Manuel has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	027	Voltage-Gated Potassium Channel Antibody-Mediated Encephalitis in Siblings	Disclosure: Dr. Woodward has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	027	Utilizing Single Cell Immune Profiling to Identify Serum-based Biomarkers for Transient Ischemic Attacks	Disclosure: Dr. Therkelsen has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	027	Readmissions after Guillain-Barré Syndrome: Nationally Representative Data	Disclosure: Dr. Roberts has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	027	Using Data Mining Tools, Microservices Architecture And Artificial Intelligence Modules For The "Juvenile Myoclonic Epilepsy JME-1000 Project"	Disclosure: Dr. Discua has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	027	Genomic Signatures From Bench to Bedside - a Protocol for Translation: sigQC	Disclosure: Dr. Dhawan has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	027	Determinants of Weight Change in Parkinson's Disease	Disclosure: Dr. Herndon has nothing to disclose.
Research Methodology and Education: Graduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	027	Surveying the Clinical Learning Environment in Terms of Wellness, Burnout, Psychological Safety, and Mistreatment in a Neurology Residency Program at an Academic Medical Centre	Disclosure: Dr. Schachter has nothing to disclose.
Cognitive Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	028	Early in vivo signatures of neurodegeneration at individual level in isolated REM behaviour disorder	Disclosure: Dr. Carli has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	028	A Report on LGI1 Encephalitis in association with Squamous Cell Carcinoma of the Lung	Disclosure: Dr. Virupakshaiah has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	028	Neuroprotection by Non Steroidal Anti-Inflammatory Drugs Against an In Vivo & In Vitro Ischemic Stroke via Downregulating Intrinsic Apoptosis Pathways.	Disclosure: Dr. Tripathi has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	028	Prospective, Open-Label Study Evaluating the Safety and Tolerability of Higher Infusion Rates of Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy. Interim analyses.	Disclosure: Dr. Jiang has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	028	Improving Lennox-Gastaut Syndrome from Diagnosis to Management through Online Continuing Education: Changes in Patient Experience, Clinical Practice, and Provider Knowledge and Competence	Disclosure: Dr. Turell has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	028	Using PIK3CB and Connexin-43 Inhibition to Sensitize Glioblastoma Cells to Temozolomide	Disclosure: Dr. Shah has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	028	Mild Cognitive Impairment changes Natural Reading in Parkinson‘s Disease	Disclosure: Dr. Waldthaler has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	028	Osler Apprenticeship Program: Impact of peer advising on medical student preparedness and experience in the Neurology Clerkship	Disclosure: Dr. Shrock has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies I
Start Time	Pub.	Title	Presenter
11:30 AM	029	The UCSF Memory and Aging Center: Early Developmental History Screening Questionnaire	Disclosure: Dr. Shwe has nothing to disclose.
Autoimmune and Paraneoplastic Encephalitis
Start Time	Pub.	Title	Presenter
11:30 AM	029	Refractory LGI-1 Limbic Encephalitis and Secondary Mesial Temporal Lobe Epilepsy: A Case Report	Disclosure: Dr. Khan has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	029	Glutamate Induces Synthesis of Thrombogenic Peptides and Extracellular Vesicle Release from Human Platelets	Disclosure: Dr. Gautam has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	029	The Recovery of Severe Foot Drop in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in relation to Electrodiagnostic Findings of the Affected Tibialis Anterior (TA) Muscle	Disclosure: Dr. Weerasinghe has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	029	Predictors of 30-day readmission after index hospitalization for epilepsy: a 5-year national estimate using the Nationwide Readmission (NRD) database	Disclosure: Dr. Savani has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	029	Comparative Analysis of Tumor Treating Fields Using Conventional versus Alternative Transducer Array Placement for Posterior Fossa Glioblastoma	Disclosure: Dr. Wong has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Advance Medical, Merck, and Novocure. Dr. Wong has received research support from Novocure.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	029	Impulse Control Disorders in Parkinson’s disease – a cross-sectional and longitudinal study of severity	Disclosure: Dr. Baig has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	029	The Effects of Residents’ teaching on Medical Students’ Neurology Experience and Interest	Disclosure: Dr. Keser has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies I
Start Time	Pub.	Title	Presenter
11:30 AM	030	Cognitive Profiles in Amyloid-Positive Mild Cognitive Impairment and Alzheimer’s Disease with and without Tau	Disclosure: Dr. McCollum has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	030	Presence of Systemic Autoantibodies and Associated Comorbid Conditions in a Large Cohort of Stiff Person Syndrome	Disclosure: Dr. Comisac has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	030	Serum Troponin Level In Acute Ischemic Stroke Identifies Patients with Concomitant Visceral Infarcts	Disclosure: Dr. Azher has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	030	A 65 year old man with MADSAM associated with neurosarcoidosis	Disclosure: Dr. Harada has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	030	How Common Are Idiopathic Seizures in the Elderly? A Retrospective Review.	Disclosure: Dr. Beers has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	030	Impact of EGFR Amplification in Newly Diagnosed Glioblastoma Treated with Adjuvant Temozolomide: Four-year experience of a single major tertiary care institution	Disclosure: Dr. Barnett holds stock and/or stock options in Monteris Medical Inc. which sponsored research in which Dr. Barnett was involved as an investigator. Dr. Barnett holds stock and/or stock options in Monteris Medical Inc..
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	030	Neural Correlates of Impaired Motivation in Parkinson’s Disease	Disclosure: Dr. Massimo has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	030	Empowering residents to enhance Medical Students' Education during their Neurology Clerkship	Disclosure: Dr. Rodriguez-Linares has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies I
Start Time	Pub.	Title	Presenter
11:30 AM	031	Cognitive Decline Over 18 Months in Patients With Mild Cognitive Impairment or Dementia due to Alzheimer’s Disease	Disclosure: Dr. Lim has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	031	F/M Wave Area And F-Wave Duration Quantify Spinal Hyperexcitability in Glutamic Acid Decarboxylase (GAD) Antibody Positive Patients with Stiff Person Syndrome.	Disclosure: Dr. Shbeb has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	031	Low Holotrancobalamin- A Risk Factor And Better Marker Than Cobalamin And Homocysteine In Acute Stroke.	Disclosure: Dr. Sagvekar has nothing to disclose.
Acquired Neuropathies I
Start Time	Pub.	Title	Presenter
11:30 AM	031	Role of Cerebrospinal Fluid Protein and Laboratory Testing in Guillain Barre Syndrome	Disclosure: Dr. Saba has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	031	Differential diagnosis of epileptic seizure and syncope using machine learning algorithms	Disclosure: Dr. Kim has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	031	Factors Associated with Tumour Recurrence in WHO Grade II Meningiomas	Disclosure: Dr. Chuang has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	031	Anxiety and depression are associated with levodopa-responsive, but not levodopa-unresponsive, freezing of gait in Parkinson’s disease	Disclosure: Dr. McKay has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	031	Can students help bridge the great divide? Student perceptions of neurology and psychiatry clerkship integration	Disclosure: Dr. Mowchun has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies I
Start Time	Pub.	Title	Presenter
11:30 AM	032	Prosodic Impairment as a Marker of apoE4 Status in logopenic variant Primary Progressive Aphasia with AD Pathology	Disclosure: Dr. Nevler has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	032	Coexistence of neuromyelitis optica and stiff person syndrome in a single patient: a case report	Disclosure: Dr. Thuringer has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	032	The Relationship Between Serum Highly Sensitive C-Reactive Protein, Severity And Short-Term Outcome In Acute Stroke At The Lagos University Teaching Hospital, Lagos, Nigeria.	Disclosure: Dr. Olapeju has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	032	The effect of L-Arginine on mitochondrial function, nitric oxide synthesis and nitrative stress	Disclosure: Dr. Tengan has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	032	Long-term Follow up of Epilepsy Patients After a Single Neurologist Visit	Disclosure: Dr. Prajapati has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	032	Radiographic Appearance of Leptomeningeal Disease in Patients with EGFR Mutated Non-Small Cell Lung Carcinoma Treated with Tyrosine Kinase Inhibitors – A Case Series	Disclosure: Dr. Sener has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	032	Heart Rate Variability And Sympathetic Skin Response In Idiopathic And Leucine-Rich Repeat Kinase 2-Associated Parkinson's Disease	Disclosure: Dr. Nasri has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	032	Student Satisfaction and NBME Outcomes with Team Based Learning on the Neurology Clerkship, a Pilot Study	Disclosure: Dr. Dunham has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen and Genzyme. Dr. Dunham has received research support from Biogen.
Aging and Dementia: Neuropsychology and Clinical Studies I
Start Time	Pub.	Title	Presenter
11:30 AM	033	Creutzfeldt-Jakob Disease Masquerading as Autoimmune Encephalitis	Disclosure: Dr. Kola has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	033	Long-term Rituximab Use Benefits Patients with Stiff Person Syndrome	Disclosure: Dr. Aljarallah has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	033	Utility of D-dimer for oncologic disease suspicion in patients with cryptogenic ischemic stroke.	Disclosure: Dr. Bullrich has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	033	A novel Biological (FOX-115) improves endurance of motor performances in old mice	Disclosure: Dr. Fariello holds stock and/or stock options in PharmaFox AG which sponsored research in which Dr. Fariello was involved as an investigator. .
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	033	Differentiation of Epileptic Seizures from Dissociative Attacks, an Ongoing Dilemma.	Disclosure: Dr. Chan has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	033	Neuropsychological and resting state fMRI changes with Spiritual Practice	Disclosure: Dr. Gupta has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	033	Rapid Picture Naming in Parkinson’s Disease Using the Mobile Universal Lexicon Evaluation System (MULES) Test	Disclosure: Dr. Conway has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	033	Validity of Neurology Core Clinical Experience Score	Disclosure: Dr. Kao has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies I
Start Time	Pub.	Title	Presenter
11:30 AM	034	Elevation of 14-3-3 and Unique MRI findings in a Case of Logopenic Variant Primary Progressive Aphasia	Disclosure: Dr. Al-Hasan has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	034	Anti Glutamic Acid Decarboxylase Antibody Syndromes Occur At An Earlier Age In African Americans.	Disclosure: Dr. Sriwastava has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	034	Thromboelastography with Platelet Mapping(TEG-PM) is a Sensitive Indicator of Radiographically Confirmed Ischemic Stroke: A Retrospective Analysis.	Disclosure: Dr. Arora has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	034	Chilaiditi syndrome and radiological sign in myotonic dystrophy type 1	Disclosure: Dr. Kato has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	034	A Survey of Health Care Professionals' Perceptions of Convulsive Seizure Freedom and Antiepileptic Drug Adherence	Disclosure: Dr. Rappa has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	034	3-D Brain Tumor Modeling for Improved Patient Health Literacy and Trainee Education	Disclosure: Dr. Gatson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novocure (Optune).
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	034	Genomic variants associated with cognitive impairment in Parkinson's disease: Ethnicity-specific genome-wide association study	Disclosure: Dr. Chung has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	034	Assessment of Medical Student Clinical Skills during Neurology Clerkship: A Quality Improvement Study	Disclosure: Dr. Barnes has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lundbeck.
Aging and Dementia: Neuropsychology and Clinical Studies I
Start Time	Pub.	Title	Presenter
11:30 AM	035	An Atypical Presentation of Prion Disease with Alien Limb, Apraxia, and Intact Cognition	Disclosure: Dr. Chaudhry has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	035	Double Hit and Excellent Treatment Response: AMPA and GAD-65 Receptor Antibodies in a Young Woman with Stiff Person Plus Syndrome Misdiagnosed as Acute Scoliosis and Bipolar Disorder	Disclosure: Dr. Witek has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Preclinical Work and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	035	Differences in Admission Electrolyte Concentrations among Stroke Etiologies	Disclosure: Dr. Forman has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	035	Aliskiren and cytokine's expression in mdx mice	Disclosure: Dr. Feder has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	035	Pediatric Focal Epilepsy: Patient Characteristics, Treatment Choices, Healthcare Resource Use and Costs by Developmental Delay and Behavioral Disorders Comorbidity Subgroups: A US Claims Database Analysis	Disclosure: Dr. Thieffry has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB employee.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	035	Efficacy of Extended Adjuvant Temozolomide Cycle Duration in Newly Diagnosed Glioblastoma: Four-year experience of a single major tertiary care institution	Disclosure: Dr. Barnett holds stock and/or stock options in Monteris Medical Inc. which sponsored research in which Dr. Barnett was involved as an investigator. Dr. Barnett holds stock and/or stock options in Monteris Medical Inc..
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	035	Cognitive Improvement After Six-Week Action Observation and Motor Imagery Training in Patients with Parkinson’s Disease	Disclosure: Dr. Canu has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	035	How am I really doing in Neuro Small Group? Student Perceptions of Feedback in Neurology Case-Based Learning Sessions	Disclosure: Dr. Hogue has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	036	GAD65 and Glycine Receptor-Associated Neurologic Autoimmunity and Stiff-Person Syndrome within the University of Utah Health Care System	Disclosure: Dr. Galli has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	036	Design of a Phase III Study of Intravenous Glibenclamide (BIIB093) for Large Hemispheric Infarction: the CHARM Study	Disclosure: Dr. Sheth has received royalty, license fees, or contractual rights payments from Alva Health. Dr. Sheth has received research support from Biogen, Novartis, Bard, and Hyperfine.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	036	New Insights About Myofibrillar Myopathies: The Role Of Metalloproteinases 2 And 9 In The Pathogenesis	Disclosure: Dr. Carvalho has nothing to disclose.
Epilepsy: Diagnosis and Clinical Care I
Start Time	Pub.	Title	Presenter
11:30 AM	036	Implementation of the Liverpool Adverse Events Profile in Patients with Epilepsy at the University of Puerto Rico Epilepsy Clinics	Disclosure: Dr. Alonso-Quinones has nothing to disclose.
Basic Science and Translational Discoveries in Neuro-Oncology
Start Time	Pub.	Title	Presenter
11:30 AM	036	Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T-cells	Disclosure: Dr. Karschnia has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	036	Non-motor phenotypes in Parkinson’s disease patients with metabolic syndrome.	Disclosure: Dr. Meléndez-Flores has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	036	Development of the Summer NeuroImaging Research Program (SNIRP) for Undergraduates: Novel Research to Engage Students and Enhance the Academic Mission	Disclosure: Dr. Absher has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	037	Bortezomib for the Treatment of Refractory Stiff Person Spectrum Disorder	Disclosure: Dr. Husari has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	037	Prediction of Malignant Edema in Anterior Circulation Stroke: Validation of the EDEMA Score and Added Value of Stroke Severity	Disclosure: Dr. Cheng has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	037	Axial Weakness as the Presenting Manifestation of Myopathy	Disclosure: Dr. Parks has nothing to disclose.
Global Neurology: Clinical Research and Case Reports
Start Time	Pub.	Title	Presenter
11:30 AM	037	Developing an Inpatient Neurology Registry To Understand Neurological Disease Burden in Zambia	Disclosure: Dr. Nutakki has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	037	Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson’s disease and dementia with Lewy bodies	Disclosure: Dr. Horn has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	037	Top 5 Reasons Not to Choose Neurology as a Career	Disclosure: Dr. Vaou has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	038	Isolated Dysarthria due to Immune-mediated Brainstem Encephalitis Associated with Anti-Glutamate Acid Decarboxylase 65 antibodies	Disclosure: Dr. Dawit has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	038	Neuro-Checks and the National Institute of Health Stroke Scale in Acute Stroke	Disclosure: Dr. De Leon Benedetti has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	038	Paraspinal Atrophy Suggesting Underlying Genetic Etiology	Disclosure: Dr. Schwartz has nothing to disclose.
Global Neurology: Clinical Research and Case Reports
Start Time	Pub.	Title	Presenter
11:30 AM	038	Neurocysticercosis and HIV Among Zambian Youth: A Geographic Approach	Disclosure: Dr. Buda has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	038	Diminished fMRI global signal differences between eyes closed and eyes open resting state in REM behavior disorder (RBD) and Parkinson’s disease	Disclosure: Dr. Suescun has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	038	Effect of a faculty-led comprehensive mentorship program on medical student recruitment and research productivity in neurology	Disclosure: Dr. Zhu has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	039	Anti- Tr antibodies in autoimmune cerebellar ataxia: Serial antibody testing and response to immunotherapy	Disclosure: Dr. Barba has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	039	Early mobilization after 12 hours post thrombolysis is feasible and safe in minor stroke patients	Disclosure: Dr. Khan has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	039	Nitrative Stress In Skeletal Muscle Of Patients With Mitochondrial DNA Mutation	Disclosure: Dr. Livramento has nothing to disclose.
Global Neurology: Clinical Research and Case Reports
Start Time	Pub.	Title	Presenter
11:30 AM	039	GBS after the Zika-outbreak in Colombia: The newcomer is gone but the problem continues!	Disclosure: Dr. Pardo-Villamizar has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	039	Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease – A Single Center Experience	Disclosure: Dr. Chandra has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	039	Assessment of a Movement Disorders Video Curriculum for Neurology Clerkships	Disclosure: Dr. Bette has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lundbeck.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	040	Steroid therapy in probable cerebellar-type Hashimoto's encephalopathy	Disclosure: Dr. Kinoshita has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Otsuka Pharmaceutical Co., Eisai Co., Daiichi Sankyo Co., UCB Japan Co., Novartis Pharma K.K. Co.. Dr. Kinoshita has received research support from Otsuka Pharmaceutical Co., Eisai Co., Daiichi Sankyo Co..
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	040	Fast-track versus Long-term Hospitalizations for Patients with Non-disabling Acute Ischaemic Stroke	Disclosure: Dr. Fladt has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	040	A patient with Late onset Pompe Disease presenting with prominent muscle cramps, proximal lower extremities muscle weakness, and widespread myotonic discharges seen in electromyography.	Disclosure: Dr. Ewida has nothing to disclose.
Global Neurology: Clinical Research and Case Reports
Start Time	Pub.	Title	Presenter
11:30 AM	040	A Comparison of the Full Outline of Unresponsiveness (FOUR) and Glasgow Coma Scale (GCS) Scores in Predicting Mortality Among Patients with Altered Level of Consciousness in Uganda.	Disclosure: Dr. Abdallah has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	040	Kickboxing and Cognition in Parkinson's Disease	Disclosure: Dr. McLeod has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	040	Can Interactive Case-Based Modules Improve Medical Student Shelf Examination Performance?	Disclosure: Dr. Mohl has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	041	A Previously Undescribed Case of an Autoimmune Cerebellar Ataxia (ACA) Associated with a Novel Antibody Against Mouse Cerebellum.	Disclosure: Dr. Malik has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	041	Understanding the Environment of Care for Hospitalized Stroke Patients	Disclosure: Dr. Chao has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	041	Exome sequencing reveals novel candidate genes and potential oligogenic inheritance in patients with the complex trait arthrogryposis	Disclosure: Dr. Pehlivan has nothing to disclose.
Global Neurology: Clinical Research and Case Reports
Start Time	Pub.	Title	Presenter
11:30 AM	041	Jellyfish Envenomation causing Irukandji Syndrome Presenting as Generalized Muscle Spasms in a Young Adult Male in Laiya, Batangas, Philippines- A Case Report.	Disclosure: Dr. Matic has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	041	Usefulness of the Stroke Drivers Screening Assessment (SDSA) in patients with Parkinson’s syndrome	Disclosure: Dr. Morimoto has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	041	Medical Student Assessment Across Multiple Clinical Campuses: Are We Consistent?	Disclosure: Dr. Braksick has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	042	Bilateral Horizontal Gaze Paralysis - Case Series	Disclosure: Dr. Bansal has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	042	Disparities in the effect of atrial fibrillation on discharge destination and length of stay in patients hospitalized for ischemic stroke: the Florida Puerto Rico Atrial Fibrillation Stroke Study	Disclosure: Dr. Sur has received research support from StrokeNet NIH Grant.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	042	A unique myopathic phenotype of novel SPTAN1 mutation without encephalopathy in siblings	Disclosure: Dr. Anilkumar has nothing to disclose.
Global Neurology: Clinical Research and Case Reports
Start Time	Pub.	Title	Presenter
11:30 AM	042	Diagnosis and Treatment of Neuromyelitis Optica in Ethiopia	Disclosure: Dr. Delaney has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	042	“Incomplete Design” Errors Distinguish Design Fluency Performance in Parkinson’s Disease Patients with Left Motor Onset Symptoms	Disclosure: Dr. Wagner has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	042	You Never Forget Your First? Impact of Interview Timing on Final Rank Order	Disclosure: Dr. Schloemer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with SERMO (private social media network for physicians) .
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	043	Anti-GAD 65 Antibody Mediated Cerebellar hemiataxia	Disclosure: Dr. Alchaki has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	043	Practice Alert: Generalized Tonic-Clonic Seizures Associated with Intra-arterial Administration of High Doses of Verapamil in Treatment of Cerebral Vasospasm	Disclosure: Dr. Ziu has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	043	Molecular link between insulin resistance and skeletal muscle atrophy in myotonic dystrophies	Disclosure: Dr. Meola has nothing to disclose.
Global Neurology: Education and Health Systems Research
Start Time	Pub.	Title	Presenter
11:30 AM	043	Neurology International Residents Videoconference and Exchange (NIRVE)	Disclosure: Dr. Sasikumar has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	043	Comparison of EEG Connectivity measures and Frequency analysis for identification of patients with Mild Cognitive Impairment in Parkinson´s disease – a Random Forest Analysis	Disclosure: Dr. Chaturvedi has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	043	Disclosure of Medical Errors in Stroke Patients: A Randomized Controlled Trial in a Simulation Curriculum	Disclosure: Dr. Barratt has received research support from the American Academy of Neurology.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	044	A Rare Case of Non-Neoplastic Anti-GAD Positive Cerebellar Ataxia and Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM), Responsive to IVIG Therapy	Disclosure: Dr. Jazebi has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	044	Triage of Acute Strokes Using an EMS-driven Rapid Arterial Occlusion Evaluation (RACE) Protocol: a Longitudinal Study.	Disclosure: Dr. Afreen has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	044	Low Dose Dantrolene Treatment Reduced Pain in Patients with Strongman Syndrome.	Disclosure: Dr. Chamard Witkowski has nothing to disclose.
Global Neurology: Education and Health Systems Research
Start Time	Pub.	Title	Presenter
11:30 AM	044	Global Health Education in Child Neurology and Neurodevelopmental Disabilities Training Programs: A National Survey	Disclosure: Dr. Jimenez Gomez has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	044	Longitudinal Cortical Changes Associated With Apathy in Parkinson’s Disease	Disclosure: Dr. imperiale has nothing to disclose.
Research Methodology and Education: Undergraduate Education
Start Time	Pub.	Title	Presenter
11:30 AM	044	The Addition of Virtual Reality into the Neurology Curriculum	Disclosure: Dr. Holton-Burke has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	045	Patterns of Brain Volume Loss in Traumatic Brain Injury	Disclosure: Dr. Meysami has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	045	Paraneoplastic cerebellar degeneration in a woman with gastric adenocarcinoma	Disclosure: Dr. Lauritsen, DO has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	045	Improving field Identification of Large vessel occlusion: A retrospective review analysis	Disclosure: Dr. Grewal has nothing to disclose.
Genetic Muscle Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	045	Novel missense mutation in CAPN3 gene detected in a tunisian family with limb girdle muscular dystrophy type 2	Disclosure: Dr. Rekik has nothing to disclose.
Global Neurology: Education and Health Systems Research
Start Time	Pub.	Title	Presenter
11:30 AM	045	Global Teleneurology Service: First Insights	Disclosure: Dr. Bove has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alexion, Roche Genentech, Novartis, EMD Serono, Biogen, Sanofi Genzyme, and Pear Digital. Dr. Bove has received research support from Akili Interactive.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	045	Profile of Non-motor Symptoms and Impact on Quality of Life of Parkinson Disease Patients in a Neurology Clinic in Lagos Nigeria	Disclosure: Dr. Arabambi has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	046	Exosomal and Plasma Protein Biomarkers of Neuronal Injury and Inflammation in Chronic Mild TBI: A Chronic Effects of Neurotrauma Consortium (CENC) Biomarker Discovery Project	Disclosure: Dr. Kenney has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	046	Autoimmune dystonia – a group of patients responsive to immunotherapy	Disclosure: Dr. Sioufi has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	046	A Prehospital Los Angeles motor scale (LAMS) score of 4 or more predicts intervention for acute stroke.	Disclosure: Dr. Stead has nothing to disclose.
Global Neurology: Education and Health Systems Research
Start Time	Pub.	Title	Presenter
11:30 AM	046	Task-shifting to Optimize Outpatient Neurological Care in Zambia	Disclosure: Dr. Villegas has nothing to disclose.
Parkinson's Disease Non-Motor Symptoms
Start Time	Pub.	Title	Presenter
11:30 AM	046	Cholinesterase Inhibitor Taper Worsens Symptoms in Patients with Parkinson’s Disease	Disclosure: Dr. Moo has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	047	Highly Sensitive Single Molecular Array Immunoassay Measurement of t-Tau, NF-L, GFAP, and UCH-L1 Biomarkers in Acute Concussion/Mild Traumatic Brain Injury (mTBI) Patient Serum and Saliva Samples	Disclosure: Dr. Chenna has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Monogram Biosciences, Laboratory Corporation of America.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	047	Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement not Responsive to Steroids – Management Decisions in a Situation of Diagnostic Uncertainty	Disclosure: Dr. Sengul has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	047	Improvement in Stroke Survey Scores for Rural EMS Providers	Disclosure: Dr. Seachrist has nothing to disclose.
Global Neurology: Education and Health Systems Research
Start Time	Pub.	Title	Presenter
11:30 AM	047	Stroke surveillance and Establishment of Acute Stroke Care Pathway in Rural Northwest India using Community Health Workers: data from Ludhiana rural population-based stroke registry	Disclosure: Dr. Pandian has nothing to disclose.
Parkinson's Disease Therapeutics I
Start Time	Pub.	Title	Presenter
11:30 AM	047	Results of a Phase 1 Dose-Ranging Trial, and Design of a Phase 2 Trial, of K0706, a Novel C-Abl Tyrosine Kinase Inhibitor for Parkinson’s Disease.	Disclosure: Dr. Goldfine has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sun Pharma Advanced Research Company.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	048	CTE Pathology Absent in Former Military Services Members: A Preliminary Study Demonstrating No Increase in Neurodegenerative Proteinopathy Following TBI	Disclosure: Dr. Tripathy has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	048	The Hand that Danced: A Case of Seronegative NMO presenting with Pseudoathetosis	Disclosure: Dr. Boddu has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	048	Reasons for Prehospital Delay in Acute Ischemic Stroke: a Prospective Cohort Study	Disclosure: Dr. Fladt has nothing to disclose.
Global Neurology: Education and Health Systems Research
Start Time	Pub.	Title	Presenter
11:30 AM	048	Challenges Faced in Semi Urban & Rural Rehabilitation Center: A single Center Prospective Study from India	Disclosure: Dr. Ruikar has nothing to disclose.
Parkinson's Disease Therapeutics I
Start Time	Pub.	Title	Presenter
11:30 AM	048	Efficacy results of a 12-month, dose-level blinded study of CVT-301 (levodopa inhalation powder) in patients with Parkinson’s disease	Disclosure: Dr. Farbman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Dr. Farbman has received honoraria for advisory board participation from Teva Pharmaceuticals and UCB.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	049	Chronic Neurobehavioral Symptoms in Retired Athletes and Military Veterans with a History of Head Trauma	Disclosure: Dr. Darby has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	049	Paraneoplastic Syndrome with a Progressive Supranuclear Palsy phenotype	Disclosure: Dr. Amireh has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	049	RAcial Disparities in Ich After iv-tpA and Neurointerventional Treatment (RADIANT)	Disclosure: Dr. Chiang has nothing to disclose.
Global Neurology: Education and Health Systems Research
Start Time	Pub.	Title	Presenter
11:30 AM	049	Electronic Fetal Monitoring as a Remedy for Cerebral Palsy in Africa: First Do No Harm	Disclosure: Dr. Johnston has nothing to disclose.
Parkinson's Disease Therapeutics I
Start Time	Pub.	Title	Presenter
11:30 AM	049	Preclinical Development of a Novel Precision Olfactory Delivery (POD®) - L-dopa Drug-Device Combination Product for the Treatment of OFF Episodes in Parkinson’s Disease	Disclosure: Dr. Satterly has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Impel NeuroPharma.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	050	Ice Hockey Head Impact Kinematics Are Not Associated with Changes in Clinical Concussion Measures	Disclosure: Dr. Buckley has nothing to disclose.
Autoimmune or Paraneoplastic Movement Disorders: Stiff Person Syndrome and Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	050	A Young Woman with Palatal Myoclonus, Memory loss and Seizures	Disclosure: Dr. Allen has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Prehospital and In-patient Evaluation and Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	050	Cerebral Oximetry in Acute Ischemic Stroke Patients According to Brain Area and Recanalization Status	Disclosure: Dr. Giacalone has nothing to disclose.
Parkinson's Disease Therapeutics I
Start Time	Pub.	Title	Presenter
11:30 AM	050	Gastric Retention of the Accordion Pill™: Results From MRI Studies With Parkinson’s Disease Patients and Healthy Volunteers	Disclosure: Dr. Navon has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities as an employee of Intec Pharma. .
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	051	Use of a Novel Clinically Relevant Symptom Scale for Acute Concussion	Disclosure: Dr. McCarthy has received research support from Riddell.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	051	Discovering Context-dependent Whole Blood Gene Expression Quantitative Trait Loci (eQTL) In Relapsing Remitting Multiple Sclerosis	Disclosure: Dr. Partha has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen.
Pediatric Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	051	A Life Saving Treatment in an Adolescent Girl Presenting with Headache and Stupor	Disclosure: Dr. Mandge has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	051	Modes of death of hospitalized patients with Parkinson’s disease: a 12-year retrospective analysis	Disclosure: Dr. Auffret has nothing to disclose.
Parkinson's Disease Therapeutics I
Start Time	Pub.	Title	Presenter
11:30 AM	051	ITI-214, A Novel Phosphodiesterase I Inhibitor for the Treatment of Parkinson's Disease: Results from A Phase I/II Clinical Study	Disclosure: Dr. Davis has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with IntraCellular Therapies.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	052	Abnormal Levels of Expired End-Tidal Carbon Dioxide (ETCO2) are Associated with Severity of Injury in Adults with Mild to Moderate Traumatic Brain Injury at a Level I Trauma Center	Disclosure: Dr. Elsawaf has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	052	Distribution and Efficacy of Ofatumumab and Ocrelizumab in Humanized-CD20 Mice following Subcutaneous or Intravenous Administration	Disclosure: Dr. Baguña Torres has nothing to disclose.
Pediatric Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	052	Clinical Presentation, Neuroimaging Characteristics and Long-term Outcome in Pediatric Cerebral Venous Sinus Thrombosis: A Retrospective Study	Disclosure: Dr. Karakas has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	052	Psychological Attachment Styles of Surrogate Decision Makers and Neuro ICU Goals-of-Care Decisions	Disclosure: Dr. Juthani has nothing to disclose.
Parkinson's Disease Therapeutics I
Start Time	Pub.	Title	Presenter
11:30 AM	052	Efficacy of ND0612 for nocturnal problems and early morning OFF: A blinded rater study of 2 dosing regimens	Disclosure: Dr. Espay has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbvie, Neuroderm, Neurocrine, Amneal, Acadia, Acorda, Sunovion, Lundbeck, Osmotica Pharmaceutical, and USWorldMeds. Dr. Espay has received research support from NIH, Great Lakes Neurotechnologies and the Michael J Fox Foundation.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	053	MULES on the Sidelines: A Vision-Based Assessment Tool for Sports-Related Concussion	Disclosure: Dr. Fallon has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	053	IL-11 Induces Encephalitogenic Th17 cells in Experimental Autoimmune Encephalomyelitis	Disclosure: Dr. Kiapour has nothing to disclose.
Pediatric Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	053	Retrospective Cohort Analysis in Neonatal Cerebral Sinus Venous Thrombosis	Disclosure: Dr. Karakas has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	053	Advance directives of treatment in ALS patients: The Piedmont and Valle d’Aosta register experience in the 2008-2013 period.	Disclosure: Dr. Moglia has nothing to disclose.
Parkinson's Disease Therapeutics I
Start Time	Pub.	Title	Presenter
11:30 AM	053	Efficacy and Safety of Apomorphine Sublingual Film for The Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Phase 3, Double-Blind, Placebo-Controlled Trial	Disclosure: Dr. Factor has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Neurocrine, Lundbeck, Teva, Avanir, Sunovion, Adamas, Prexton, Biogen. Dr. Factor has received research support from Ipsen, Medtronics, Teva, US World Meds, Sunovion, Solstice, Vaccinex, Voyager, CHDI Foundation, Michael J. Fox Foundation, NIH.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	054	Increased Optic Nerve Sheath Diameter after Mild Traumatic Brain Injury in a High-Risk Population	Disclosure: Dr. Super has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	054	Effect of Fumarates on Human iPSC Derived Neural Progenitor Cells and Human Primary Neurons	Disclosure: Dr. Nakhaei-Nejad has nothing to disclose.
Pediatric Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	054	Endovascular Reconstruction of Intracranial Aneurysms with Pipeline in Pediatric Patients	Disclosure: Dr. Shirani has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	054	Outcomes of Patients with Cancer Related Pain Who Use Cannabis: Trends and Data from the Nationwide Inpatient Sample Database	Disclosure: Dr. Myers has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	055	Discordance of Cardiovascular Autonomic Discharge after Concussion is related to ChrM2 Gene Receptor Subtypes	Disclosure: Dr. La Fountaine has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	055	Cladribine modulates the expression of ICAM-1 and VCAM-1 on human brain endothelium; relevance to multiple sclerosis (MS)	Disclosure: Dr. Hawke has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Sanofi Genzyme, Novartis.
Pediatric Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	055	Utility of Routine Neck MRA in a Pediatric MRI Stroke Protocol	Disclosure: Dr. Baltensperger has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	055	Hospitalizations for Opioid Overdoses in the United states from 2003-2014. Trends from the Nationwide Inpatient Sample and Predictors of Mortality.	Disclosure: Dr. Gupta has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	056	Astroglial activation and altered amyloid metabolism in human repetitive concussion	Disclosure: Dr. Shahim has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	056	Evaluating the Effect of Cladribine on Marmoset B- and T-Cell Proliferation and Survival	Disclosure: Dr. Kap has nothing to disclose.
Pediatric Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	056	Screening Tool to Provide Early Stroke Detection after Cardiac Catheterization in Children	Disclosure: Dr. Salussolia has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	056	Multivariate Pattern Analysis of Emotion Regulation in Opioid-Dependent and Opioid-Naïve Chronic Pain Patients	Disclosure: Dr. Jarrahi has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	057	Plasma NF-L, tau, GFAP and advanced MRI imaging in the evaluation of mild Traumatic Brain Injury in a prospective cohort of active rugby players	Disclosure: Dr. Laverse has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	057	High Dose Biotin, MD1003, Protects Axons in a Mouse Model of Chronic Spinal Cord Demyelination	Disclosure: Dr. Warrington has received research support from MedDay.
Pediatric Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	057	Monogenic Causes of Cerebrovascular Disease in Childhood	Disclosure: Dr. Ostrem has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	057	Diffusion Tensor Tractography of Brainstem Fibers and Application to Combat-Related Pain	Disclosure: Dr. Zhang has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	058	The Effect of Repetitive Head Impact Exposure on Response Inhibition in Contact Sport Athletes	Disclosure: Dr. Bryk has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	058	The Role of Cyclophilin A in Immune-mediated CNS Inflammation	Disclosure: Dr. Oh has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	058	Spontaneous Consecutive Four Vessel Cervicocephalic Dissections and Flow-Limiting Ischemic Stroke	Disclosure: Dr. Gadani has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	058	Subjective Mental and Physical Wellbeing Correlates with Pain in Military Personnel with Trans-tibial Amputations	Disclosure: Dr. Mirman has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	059	The National Institute of Neurological Disorders and Stroke (NINDS) Updates to the Spinal Cord Injury (SCI) Common Data Element Recommendations	Disclosure: Dr. Feldman has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	059	Paracrine Modulation of Microglial Activation and Oligodendroglial Differentiation as Potential Therapeutic Mechanisms of Mesenchymal Stem Cell-Derived Neural Progenitors (MSC-NPs) Cellular Therapy in MS	Disclosure: Dr. Carling has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	059	Gene Expression Profile of Cervical Artery Dissection by Time of Event	Disclosure: Dr. Green has nothing to disclose.
Optimizing End of Life Care and Understanding Comprehensive Pain Management in the Midst of an Opioid Crisis
Start Time	Pub.	Title	Presenter
11:30 AM	059	Pain Compounding Pain: Fibromyalgia and Migraine Comorbidity	Disclosure: Dr. Bettendorf has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	060	The Life time risk after NFL, A Retrospective study	Disclosure: Dr. Kumar has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	060	Serum Exosomes from Multiple Sclerosis subjects express EBV-derived proteins and activate Monocyte-Derived Macrophages	Disclosure: Dr. Khoury has received personal compensation in an editorial capacity for Annals of Neurology---Associate Editor; Clinical Immunology ----section editor; Current treatment options in Neurology----Associate editor.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	060	Recurrent Cervicocephalic Dissections are Associated with Variants in Connective Tissue Disease Genes	Disclosure: Dr. Ridha has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	060	Nerve-Specific Local and Systemic Analgesic Effects of Acupuncture in Healthy Adults, Measured by Quantitative Sensory Testing (QST)	Disclosure: Dr. Dimitrova has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	061	ENIGMA Military Brain Injury: Altered Subcortical Volume in Chronic TBI Revealed by Mega-Analysis	Disclosure: Dr. Dennis has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	061	Thalamic Energy Dysregulation Drives Microstructural Changes Of Thalamo-Cortical Projections In Multiple Sclerosis	Disclosure: Dr. Ricigliano has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	061	IV Thrombolysis for Stroke Due to Cervicocephalic Arterial Dissection: What Is The Right Practice?	Disclosure: Dr. Khadem Alsrouji has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	061	Predictors of 30-day Readmissions and Prolonged Length of Stay Following Hospitalization for Complex Regional Pain Syndrome Type 1 - A 5-year National Estimate	Disclosure: Dr. Brock has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	062	Exosome Proteins as Prognostic and Diagnostic Biomarkers for Mild Traumatic Brain Injury	Disclosure: Dr. Flamholz has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	062	VZV-Induced Central Nervous System Vasculopathy: Clinical, Imaging and Biological Features	Disclosure: Dr. Khoury has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	062	“Burning Foot Syndrome” due to Acute Copper Deficiency Myeloneuropathy after Bariatric Surgery	Disclosure: Dr. Elsbernd has nothing to disclose.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	063	Relationship between Rapid Number and Picture Naming Tests of a Concussion Assessment Battery	Disclosure: Dr. DiFabio has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	063	Inhibition of Bruton’s Tyrosine Kinase Selectively Prevents Antigen-Activation of B cells and Ameliorates B-Cell-Mediated Experimental Autoimmune Encephalomyelitis	Disclosure: Dr. Torke has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	063	Treatment and Follow-up of VZV-Induced Central Nervous System Vasculopathy	Disclosure: Dr. Khoury has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	063	Comparison of the firing pattern of superficial dorsal horn neurons evoked by robotic and human manual brushing.	Disclosure: Dr. Lee has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Nevro Corp. Dr. Lee holds stock and/or stock options in Nevro Corp.
Neuro Trauma and Sports Neurology I
Start Time	Pub.	Title	Presenter
11:30 AM	064	The Impact of Traumatic Brain Injury on Arterial Compliance and Cerebral Blood Flow	Disclosure: Dr. Le has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	064	Novel Mouse Model to Study Cerebellar Dysfunction in Multiple Sclerosis	Disclosure: Dr. Favret has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	064	Two Cases of Transient Global Amnesia in Marfan Syndrome	Disclosure: Dr. Morris has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	064	Retrospective Diagnosis of Painful Diabetic Polyneuropathy from Electronic Abstraction of Medical Records	Disclosure: Dr. Lapin has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	065	Characterization of Myelin-reactive CD8+ T cells in Multiple Sclerosis	Disclosure: Dr. Sabatino has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	065	A unique case of Turner syndrome with spontaneous intracranial artery dissection	Disclosure: Dr. Deep has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	065	A Prospective Clinical Trial to Assess High Frequency Spinal Cord Stimulation (HF-SCS) at 10 kHz in the Treatment of Chronic Intractable Pain from Peripheral Polyneuropathy	Disclosure: Dr. Galan has nothing to disclose.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	065	Neurological Outcomes in Cardiac Arrest Patients with Non-shockable vs. Shockable Rhythm Treated With Targeted Temperature Management	Disclosure: Dr. Hari has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	066	Pharmacokinetic/Pharmacodynamic Characterization of Siponimod (BAF312) in Blood versus Brain in Experimental Autoimmune Encephalomyelitis Mice	Disclosure: Dr. Bigaud has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis Pharma AG, Basel, Switzerland..
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	066	Clinicoradiographic Course of Focal Intracranial Arteriopathy in Young Adults	Disclosure: Dr. MacLellan has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	066	High Frequency Spinal Cord Stimulation (HF-SCS) at 10 kHz for the Treatment of Neuropathic Limb Pain from Painful Diabetic Neuropathy	Disclosure: Dr. Argoff has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Needs to be Completed . Dr. Argoff has received personal compensation in an editorial capacity for Needs to be completed. Dr. Argoff has received research support from Needs to be completed.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	066	Evidence of Late Cognitive Recovery after Cardiac Arrest with Anoxia and Extended Coma	Disclosure: Dr. Sehgal has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	067	Oligodendroglial FGFR1 gene targeting protects against cerebellar demyelination and axonal degeneration in MOG35-55 induced chronic EAE	Disclosure: Dr. Rajendran has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	067	Racial disparities in moyamoya disease in a North American cohort	Disclosure: Dr. Irshad has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	067	Dorsal Root Ganglion Stimulation: A Potentially Effective Treatment for Painful Hereditary and Idiopathic Axonal Polyneuropathy	Disclosure: Dr. Ho has nothing to disclose.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	067	Efficacy of Early Neurological Examination in Determining Survival in Post Cardiac Arrest Patients who Underwent Hypothermia Protocol	Disclosure: Dr. Hanumanthu has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	068	Single Cell Analysis of Acute Inflammatory Demyelinating Syndromes Identify Cell States Enriched for MS Susceptibility	Disclosure: Dr. Diaconu has nothing to disclose.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	068	Is there a distinct phenotype for non-Asian moyamoya patients?	Disclosure: Dr. Gatollari has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	068	CONVEY, A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study Design of Vixotrigine for the Treatment of Pain in Participants With Confirmed Small Fiber Neuropathy	Disclosure: Dr. Shinobu has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities as an employee of Biogen and on the Scientific Advisory Board for Inscopix Inc. Former employee of Decibel Therapeutics and Voyager Therapeutics. Dr. Shinobu holds stock and/or stock options in Decibel Therapeutics which sponsored research in which Dr. Shinobu was involved as an investigator.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	068	NeuroCardiac Comprehensive Care Clinic Seeks to Define and Detect Neurological, Psychiatric, and Functional Sequelae in Cardiac Arrest Survivors	Disclosure: Dr. Ghazali has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	069	Dimethyl Fumarate Exerts Selective Effects on Key B Cell Subsets and IgG Levels Which May Contribute to its Therapeutic Benefit in MS While Maintaining Protective Humoral Immunity	Disclosure: Dr. Bar-Or has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with speaker/consulting fees/grant support from Atara Biotherapeutics, Biogen, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, MedImmune, Merck/EMD Serono, Novartis and Sanofi-Genzyme. Dr. Bar-Or has received research support from grant support from Atara Biotherapeutics, Biogen, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, MedImmune, Merck/EMD Serono, Novartis and Sanofi-Genzyme.
Dissection and Vasculopathy
Start Time	Pub.	Title	Presenter
11:30 AM	069	Moyamoya Disease and Associated Risk Factors: Analysis of a National Database	Disclosure: Dr. Gupta has nothing to disclose.
The Extremes of Extremity and Back Pain
Start Time	Pub.	Title	Presenter
11:30 AM	069	Electrical Impedance Myography for Assessing Patients with Low Back Pain	Disclosure: Dr. Rutkove has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Myolex, Biogen, Axcella Health, Merck. Dr. Rutkove has received personal compensation in an editorial capacity for Annals of Neurology. Dr. Rutkove has received compensation for serving on the Board of Directors of Myolex, Inc. Dr. Rutkove holds stock and/or stock options in Myolex, Inc.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	069	Is Therapeutic Hypothermia For Cardiac Arrest Changing Outcomes: A National Inpatient Sample Analysis 2008-2014	Disclosure: Dr. Afzal has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	070	Single-Cell Genomics Reveals Spatial and Stage-Associated Diversity in Multiple Sclerosis	Disclosure: Dr. Schirmer has nothing to disclose.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	070	National Trends in Utilization of Therapeutic Hypothermia for Cardiac Arrest: National Inpatient Sample Study 2008-2014	Disclosure: Dr. Qureshi has nothing to disclose.
TRANSCENDS Scholarship Recipients
Start Time	Pub.	Title	Presenter
	070	Jumping as a Strategy to Overcome Freezing of Gait while Turning in Parkinson’s Disease	Karlo Lizarraga Disclosure: Dr. Lizarraga has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	071	Dimethyl Fumarate (DF) Suppresses GMCSF-producing Th1 cells in EAE and human CD4 T cells.	Disclosure: Dr. Safavi has nothing to disclose.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	071	Ischemic stroke after targeted temperature management for out-of-hospital cardiac arrest: A MRI findings	Disclosure: Dr. Baik has nothing to disclose.
TRANSCENDS Scholarship Recipients
Start Time	Pub.	Title	Presenter
	071	Association of Inflammation and Neurocognitive Impairment in Older Hispanics Living with HIV	Monica Diaz Disclosure: Dr. Diaz has nothing to disclose.
Large Artery Disease and Stroke
Start Time	Pub.	Title	Presenter
	072	Witnessed Apneas During Sleep are Associated with Elevated Tau-PET Signal in the Entorhinal Cortex in Cognitively Unimpaired Elderly	Diego Carvalho Disclosure: Dr. Carvalho has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	072	Flotillin-1/2 autoantibodies in patients with inflammatory disorders of the CNS	Disclosure: Dr. Mariotto has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck for attending a neurological meeting .
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	072	High Motor Glascow Coma Scale score is associated with Survival to Discharge in Cardiac Arrest Patients: Retrospective Data from the MOCHA Study	Disclosure: Dr. Duskin has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	073	Intrathecal Injections of Primary Progressive Multiple Sclerosis Derived Antibodies Result in Motor Deficits and CNS Pathology in Mice Suggesting Leading Role of Antibodies in CSF Effects	Disclosure: Dr. Cali has nothing to disclose.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	073	Variability in post-arrest prognosis knowledge by healthcare providers	Disclosure: Dr. Menon has nothing to disclose.
TRANSCENDS Scholarship Recipients
Start Time	Pub.	Title	Presenter
	073	Prevalence and Prognosis of Atrial Fibrillation Among Hospitalized Ischemic Stroke Patients with Comobid Seizures in the United States	Alain Lekoubou Looti Disclosure: Dr. Lekoubou Looti has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	074	Establishment of Neurofilament Light Chain (NfL) SIMOA assay as well as a conversion factor to enable comparison to historical results using Bovine calibrators.	Disclosure: Dr. Hendricks has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech, Inc.
Neurocritical Care: Cardiac Arrest
Start Time	Pub.	Title	Presenter
11:30 AM	074	Racial Differences In Hospital Utilization Of Therapeutic Hypothermia Among Cardiac Arrest Patients In United States	Disclosure: Dr. Afzal has nothing to disclose.
TRANSCENDS Scholarship Recipients
Start Time	Pub.	Title	Presenter
	074	Seizure Comorbidity Increases Odds Of 30-Day Readmission After an Index Hospitalization for Sepsis	Alain Lekoubou Looti Disclosure: Dr. Lekoubou Looti has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	075	The Role of Pericytes in the Pathophysiology of Multiple Sclerosis	Disclosure: Dr. Tuzun has nothing to disclose.
Neurocritical Care: Epilepsy and Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	075	Safe and effective use of prolonged, 4-week therapeutic hypothermia for super-refractory status epilepticus.	Disclosure: Dr. Lee has nothing to disclose.
TRANSCENDS Scholarship Recipients
Start Time	Pub.	Title	Presenter
	075	Recruitment of Minority Populations with Parkinson's disease at an Urban Hospital	Chantale Branson Disclosure: Dr. Branson has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	076	Regulatory T cells Modulate B-cell Calcium Fluctuation	Disclosure: Dr. Haas has nothing to disclose.
Neurocritical Care: Epilepsy and Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	076	Impact of Early Treatment on Duration and Outcomes in Status Epilepticus	Disclosure: Dr. Chuck has nothing to disclose.
TRANSCENDS Scholarship Recipients
Start Time	Pub.	Title	Presenter
	076	Assessing the social determinants of health in Tourette Syndrome	Marisela Dy Disclosure: Dr. Dy has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	077	Inhibition of Bruton’s Tyrosine Kinase Prevents Inflammatory Macrophage Differentiation: A Potential Role in Multiple Sclerosis	Disclosure: Dr. Beguem Alankus has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck KGaA.
Neurocritical Care: Epilepsy and Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	077	Treatment Comparison of Critically Ill Patients with Non-Convulsive Seizures or Non-Convulsive Status Epilepticus Receiving Levetiracetam Prophylaxis	Disclosure: Dr. Kaleem has nothing to disclose.
TRANSCENDS Scholarship Recipients
Start Time	Pub.	Title	Presenter
	077	Chronic episodic cortical spreading depressions induce trigeminal allodynia and anxiety behavior	Andrea Harriott Disclosure: Dr. Harriott has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	078	Microarray Analysis Indicates Altered Expression Levels of B Cell Genes in Benign Multiple Sclerosis	Disclosure: Dr. Turkoglu has nothing to disclose.
Neurocritical Care: Epilepsy and Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	078	Racial Disparity in the Development of Seizure as a Delayed Complication of Subdural Hematoma	Disclosure: Dr. Brown has received research support from American Heart Association Young Investigator Database Research Seed Grant.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	079	A Study of Long Noncoding RNAs Expression Levels in the CSF of Multiple Sclerosis Patients	Disclosure: Dr. Iacoangeli has nothing to disclose.
Neurocritical Care: Epilepsy and Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	079	Incidence of Seizures with Fat Embolism Syndrome and Impact on Outcome: An Analysis of National Inpatient Sample Database	Disclosure: Dr. Teklemariam has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	080	Analyzing Normal and Multiple Sclerosis Brain Cells Using Single-Nucleus RNA Sequencing: Transcriptome Analyses of Normal and Diseased Cells Expressing S1P Receptors and Related Enzymatic Genes	Disclosure: Dr. Siddoway has received research support from Novartis Pharmaceuticals.
Neurocritical Care: Epilepsy and Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	080	Ketamine does not affect Intracranial Pressure in patients with brain injury but effectively suppresses Cortical Spreading Depolarization	Disclosure: Dr. Abbas has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	081	Effect of Route of Administration on the Biodistribution of a Novel Anti-CD20 Antibody in Experimental Autoimmune Encephalomyelitis-Variant Mice	Disclosure: Dr. Migotto has received research support from the University of Queensland and Novartis Pharma AG.
Neurocritical Care: Epilepsy and Status Epilepticus
Start Time	Pub.	Title	Presenter
11:30 AM	081	Association of rhythmic and periodic EEG patterns in ICU patients and in-hospital mortality	Disclosure: Dr. Muniz has nothing to disclose.
Medical Student Essay Award Recipients
Start Time	Pub.	Title	Presenter
	082	Synaptic Organization of the Reciprocal Circuit Linking the Prefrontal Cortex and the Basolateral Amygdala	Laura McGarry Disclosure: Dr. McGarry has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	082	NfL Levels in CSF, Serum, and Plasma of RRMS and PPMS Patients in a Cross-sectional UCSF Cohort	Disclosure: Dr. Harp has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech.
Medical Student Essay Award Recipients
Start Time	Pub.	Title	Presenter
	083	Intensive Blood Pressure Treatment in Deep Intracerebral Hemorrhage	Audrey Leasure Disclosure: Dr. Leasure has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	083	Cross-talk between Multiple Sclerosis (MS)-relevant B cell subsets and myeloid cells: potential contribution to the CNS-compartmentalized inflammation associated with disease progression	Disclosure: Dr. Touil has nothing to disclose.
Medical Student Essay Award Recipients
Start Time	Pub.	Title	Presenter
	084	The Civil War Soldier as the Model for Treating Hysterical Women in the 19^th Century	Stephanie Roses Disclosure:
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	084	CD39/CD73 Implication In Neuro-immunological Inflammatory Disorders	Disclosure: Dr. Kchaou has nothing to disclose.
Medical Student Essay Award Recipients
Start Time	Pub.	Title	Presenter
	085	Predicting benign brachial monomelic amyotrophy: factors at presentation that differentiate from amyotrophic lateral sclerosis	Sona Mistry Disclosure: Dr. Mistry has nothing to disclose.
MS Immunology and Basic Science
Start Time	Pub.	Title	Presenter
11:30 AM	085	Melanoma cell adhesion molecule-expressing memory helper T cells in CNS-demyelinating diseases	Disclosure: Dr. Ikeguchi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Otsuka Pharmaceutical Co., Ltd and Alexion Pharmaceuticals Co., Ltd.
11:30 AM	086	Axons Exposed to an Inflammatory Stimulus are Vulnerable to Damage by CD8+ Cytotoxic T Cells Implicated in Axon Injury	Disclosure: Dr. Schmalstieg has nothing to disclose.
11:30 AM	087	Longitudinal Expression of Gluco- and Mineralocorticoid Receptors and their Targets in Multiple Sclerosis	Disclosure: Dr. Goedel has nothing to disclose.
11:30 AM	088	Effect of Subcutaneous Treatment With Anti-CD20 Antibody on B-cell Depletion in a Lipopolysaccharide-Induced Inflammatory Mouse Model	Disclosure: Dr. Dawson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis Pharma AG.
11:30 AM	089	Human MAIT Cell Response Shows Subset Diversity in Multiple Sclerosis	Disclosure: Dr. Correale has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Argentina, Teva Argentina, Novartis Argentina and MERCK Argentina, and Merck/Serono Argentina and Novartis Argentina.
11:30 AM	090	Transcriptional Profiling of Autologous Bone Marrow Mesenchymal Stem Cell-Derived Neural Progenitors (MSC-NPs) from Patients with Multiple Sclerosis	Disclosure: Dr. Greenwald has nothing to disclose.
11:30 AM	091	Co-existence of Multiple Sclerosis and Anti-NMDA Receptor Encephalitis: What We Can Learn From It?	Disclosure: Dr. Gulec has nothing to disclose.
11:30 AM	092	Cerebrospinal Fluid of Primary Progressive MS Patients Impairs Remyelination in an Experimental Model of Multiple Sclerosis	Disclosure: Dr. Roselle has nothing to disclose.
11:30 AM	093	Nilotinib-associated Demyelinating Disease	Disclosure: Dr. Judge has nothing to disclose.
11:30 AM	094	Longitudinal Changes in the Expression of IL-33 in Relapsing Remitting Multiple Sclerosis	Disclosure: Dr. Sriram has received research support from EMD Serono.
11:30 AM	095	Neuroblastoma Cell Line and Lymphocytes Talk for Cladribine Influenced Apoptosis and Inflammation Pathways in Multiple Sclerosis (MS): An “In Vitro” Study	Disclosure: Dr. Ruggieri has nothing to disclose.
11:30 AM	096	Gene Expression Profiles of Proteins Involved in Cladribine Metabolism and their Possible Correlation with Epstein-Barr Virus Variants	Disclosure: Dr. Mechelli has received research support from Multiple Sclerosis Foundation (FISM).
11:30 AM	097	A novel mouse model of demyelinated lysolecithin lesions at different stages of remyelination	Disclosure: Dr. Bonsignore has nothing to disclose.
11:30 AM	098	From Mouse to Man – Translational Aspects of Serum Neurofilament Light Chain in Multiple Sclerosis	Disclosure: Dr. Zipp has nothing to disclose.
Autoimmune Neuromuscular Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	099	Peripheral Nerve Hyperexcitability Syndromes: a Single Center Experience.	Disclosure: Dr. Spagni has nothing to disclose.
11:30 AM	100	Prevalence of Axonal sensory neuropathy with IgM binding to Trisulfated heparin disaccharide (TS-HDS) in patients with Fibromyalgia	Disclosure: Dr. Malik has nothing to disclose.
11:30 AM	101	Calcineurin Inhibitors Can Be Safely Reduced in Most Patients with Well-controlled Myasthenia Gravis.	Disclosure: Dr. Takahashi has nothing to disclose.
11:30 AM	102	Comparison of the Quantitative Myasthenia Gravis (QMG) and Myasthenia Gravis Activities of Daily Living (MG-ADL) scores in the MGTX Randomized Trial	Disclosure: Dr. McPherson has received research support from Ra Pharmaceuticals, Alexion Pharmaceuticals, Myasthenia Gravis Foundation of America.
11:30 AM	103	Bilateral sixth nerve cranial palsy: Should we think of Myasthenia Gravis?	Disclosure: Dr. Poveda has nothing to disclose.
11:30 AM	104	CIDP Disease Burden: Results of a US Nationwide Patient Survey	Disclosure: Dr. Allen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with CSL Behring, Biotest, Alexion, Argenyx, Akcea. Dr. Allen has received research support from CSL Behring .
11:30 AM	105	Does CIDP Increase The Risk of Acquiring Other Autoimmune Disorders? A New York State Planning and Research Cooperation System Database Analysis (1998-2014)	Disclosure: Dr. Islam has nothing to disclose.
11:30 AM	106	First Report of Confirmed CIDP in a Patient with Neuromyelitis Optica Spectrum Disorder (NMOSD)	Disclosure: Dr. Murthy has nothing to disclose.
11:30 AM	107	Refractory Contactin-1-seropositive chronic inflammatory demyelinating polyneuropathy with involvement of cranial nerves: A case report.	Disclosure: Dr. Garrido Sanabria has nothing to disclose.
11:30 AM	108	Serological and Clinical Profile of Antibody Positive Autoimmune Gastrointestinal Dysmotility Patients Receiving IVIg	Disclosure: Dr. Yan has nothing to disclose.
11:30 AM	109	Miller-Fisher Syndrome Presenting in an Air Force Recruit with Extensive Maxillary Sinus Disease as Unilateral Ophthalmoplegia	Disclosure: Dr. Jordan has nothing to disclose.
11:30 AM	110	Novel Findings in Hereditary Sensory and Autonomic Neuropathy Type IV	Disclosure: Dr. Varma-Doyle has nothing to disclose.

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Saturday, May 4, 2019
7:00 AM-9:00 AM
C1 - What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Daniel Kaufer MD, FAAN
C3 - Clinical EEG: Normal EEG, Normal Variants, and How to Avoid The Common Pitfall of Over-reading Selim Benbadis MD, FAAN
C4 - Pediatric Neuro-ophthalmology Update Christopher Glisson DO, FAAN
C5 - What Do I Do Now?: Neurologic Consultations in Cancer Patients I Jaishri Blakeley MD
C6 - Therapy of Movement Disorders: A Case-based Approach David Riley MD
C7 - Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
C8 - Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? Louis Caplan MD, FAAN
7:00 AM-12:30 PM
C9 - Clerkship and Program Directors Conference: Let’s Build an Educational Scholarly Product Zachary London MD, FAAN
8:00 AM-8:30 AM
Are you My Mentor? How to Select a Good Mentor for Your Research Center Deborah Hall MD, PhD, FAAN
9:00 AM-9:30 AM
What Should Applicants Look for in a Program? Adam De Havenon MD
How to Successfully Publish Quality Improvement Projects Anup Patel MD, FAAN
Trainee Experience: Navigating the AAN and Your Career
9:30 AM-11:30 AM
C12 - Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging, and Genetic Testing Tahseen Mozaffar MD, FAAN
C13 - Clinicopathological Correlation Session in Dementia David Irwin MD
C14 - Child Neurology: Headache Amy Gelfand MD
C15 - Clinical EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults Katherine Noe MD, PhD, FAAN
C16 - Cerebrovascular Disease I: Prevention Larry Goldstein MD, FAAN, FAHA
C17 - What Do I Do Now?: Neurologic Consultations in Cancer Patients II Patrick Wen MD, FAAN
C18 - Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
C19 - Multiple Sclerosis Overview I: Clinical Pearls Mary Willis MD, FAAN
C20 - Neurologic Complications of Medical Disease Sara Hocker MD, FAAN
10:00 AM-10:30 AM
Quality Improvement Research in Neurology Mona Bahouth MD
11:00 AM-11:30 AM
Your CV Is Talking About You Behind Your Back and Your LORs Are, Too! Na Tosha Gatson MD, PhD
11:00 AM-11:45 AM
Fellowship as a Springboard to Junior Faculty Kathryn Nevel MD
12:00 PM-12:30 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
12:00 PM-3:30 PM
Futures in Neurological Research Boot Camp Deborah Hall MD, PhD, FAAN
12:00 PM-4:00 PM
C22 - Resident Basic Science I: Neuropathology J. Clay Goodman MD, FAAN
1:00 PM-1:30 PM
Statistics: Sample Size William Meurer MD
1:00 PM-1:45 PM
Mind-body Approaches to Chronic Pain Jinny Tavee MD
Tips and Tools for Successful Recruitment Peggy Nolty
What's Going On With E/M? Luana Ciccarelli , Bruce Cohen MD, FAAN
1:30 PM-3:30 PM
C25 - Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology Tahseen Mozaffar MD, FAAN
C26 - Clinical EEG: Neonatal and Pediatric Nicholas Abend MD
C27 - Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke Andrew Naidech MD, FAAN
C34 - Evaluating Tremor in the Office Andres Deik Acosta Madiedo MD
C29 - Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
C30 - Neurologic Complications of Medical and Surgical Therapies Sara Hocker MD, FAAN
C31 - Mitochondrial Disorders in Neurology Michio Hirano MD, FAAN
C32 - The Neurology of Social Behavior Bradford Dickerson MD, FAAN
C33 - Teleneurología (Teleneurology) Susana Bowling MD
1:30 PM-4:00 PM
C35 - Educators' Leadership Program (Registration Required) Rana Said MD, FAAN
1:45 PM-2:30 PM
The Experience of Music Therapy in the Interdisciplinary Treatment of TBI Renee Pazdan MD, FAAN, Rebecca Vaudreuil EdM, MT-BC
2:00 PM-2:45 PM
A Career in Neuroimaging Michael Hutchinson MD, PhD
2:30 PM-3:15 PM
Dancing with Parkinson's Diviya Kaul MD
2:45 PM-3:30 PM
Case Studies: Ethical Conundrums in Neurology Justin Sattin MD, Winston Chiong MD, Ariane Lewis MD, Salvador Cruz-Flores MD, FAAN, Daniel Larriviere MD, JD, FAAN, James Russell MD, MS, FRPC, FAAN, William Graf MD, FAAN
3:00 PM-3:45 PM
Using Technology to Get Real Answers from Your Patients Lidia Maria Moura MD, FAAN
Interventional Neurology: Training and Practice Adnan Qureshi MD
3:00 PM-4:00 PM
AAN Business Meeting
3:45 PM-4:45 PM
Women in Neurology Jennifer Bickel MD, FAAN, Veronica Santini MD, MA, Meeryo Choe MD, Renee Pazdan MD, FAAN
4:00 PM-4:45 PM
Opioids: What Is Your State Doing to Confront This Epidemic? Donn Dexter MD, FAAN
4:15 PM-5:30 PM
Hot Topics Plenary Session Eric Klawiter MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
Telestroke Across the Continuum Amy Guzik MD
5:45 PM-6:45 PM
Advancing Medicine: Inspiration and Innovation Featuring Hugh Herr, PhD Hugh Herr PhD

Sunday, May 5, 2019
7:00 AM-7:30 AM
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Resident Evaluation of Faculty: A New Approach Deborah Fay
7:00 AM-9:00 AM
C46 - Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder) Jose Merino MD, MPhil, FAAN, Dario Beltran MD, FAAN
C36 - Mastering EMG Waveform Recognition Skills in Just Two Hours! Devon Rubin MD, FAAN
C37 - Chronic Traumatic Encephalopathy: Update Andrew Budson MD
C39 - How to Design Meaningful Clinical Trials Laurie Gutmann MD, FAAN
C40 - Child Neurology: Stroke Lori Billinghurst MD
C41 - Neuro-oncology in 2019: Navigating Current Trends Maciej Mrugala MD, PhD, MPH, FAAN
C42 - The Dystonias: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
C44 - Multiple Sclerosis Therapy: Symptom Management Andrew Solomon MD, FAAN
C45 - Status Epilepticus Stephan Schuele MD, FAAN
8:00 AM-8:30 AM
C260 - Accreditation Step by Step: From Self Study to Site Visit Crys Draconi
Neuroscience of Bias Jose Posas MD
Clerkship Director Conversation Rachel Marie Salas MD, FAAN
8:00 AM-8:45 AM
Coding for Residents Kavit Shah MD
8:30 AM-9:00 AM
C261 - How to Become An Advocate For Yourself and Your Program Sana Ghafoor MD
Neuroscience Course Director Conversation Peter Hannon MD, Madhu Soni MD, FAAN
9:00 AM-10:00 AM
C262 - Choosing, Training, Forging, and Mentoring Chief Residents: Program Coordinator Role Marla Scofield C-TAGME
9:15 AM-12:00 PM
Presidential Plenary Session Natalia Rost MD, MPH, FAAN, FAHA
11:30 AM-6:30 PM
P1 - Poster Session 1
12:00 PM-12:45 PM
Almuerzo con Colegas: Perlas clínicas/ solicitando una residencia o subespecialidad en neurología
12:00 PM-1:00 PM
Neurology Pictionary Bert Vargas MD, FAAN
1:00 PM-2:15 PM
S1 - Neuroepidemiology
1:00 PM-3:00 PM
C60 - Assessment of Rapidly Progressive Dementias I: Prion and Non-prion Neurodegenerative Diseases Michael Geschwind MD, PhD, FAAN
C49 - Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease Ralph Jozefowicz MD, FAAN, Adam Quick MD
C50 - Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke Johanna Fifi MD, FAAN
C51 - Balance and Gait Disorders Alfonso Fasano MD, PhD
C52 - Introduction to Integrative Neurology Sarah Mulukutla MD, MPH
C53 - Introduction to Primary Headache Disorders: Migraine and Other Primary Headaches Including Tension-Type, Hypnic, Primary Stabbing and Nummular Headache Syndromes, Epicrania Fugax and Retinal Migraine Deborah Friedman MD, MPH, FAAN
C56 - Multiple Sclerosis Therapy: Disease-modifying Treatment I Scott Newsome DO, FAAN
C57 - Drugs and Toxin-induced Neurologic Emergencies Sara Hocker MD, FAAN
C59 - Cuidados Neurocríticos (Neurocritical Care) Susana Bowling MD
C47 - Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies Amanda Peltier MD, MS
S2 - Neurocritical Care
S3 - Epilepsy/Clinical Neurophysiology (EEG) I
S5 - Therapeutics in ALS and SMA
S4 - Clinical Trials in Movement Disorders
S6 - MS and CNS Inflammatory Disease: Clinical Considerations I
IS1 - Invited Science: Infectious Diseases and Global Health John England MD, FAAN, Kiran Thakur MD
1:00 PM-5:00 PM
Consortium of Neurology Program Directors Business Meeting Zachary London MD, FAAN, Erica Schuyler MD, Jaffar Khan MD, FAAN
1:00 PM-5:30 PM
C64 - Skills Workshop: Neurophysiologic Intraoperative Monitoring (Registration Required) Aatif Husain MD
C63 - Resident Basic Science II: Neuropharmacology James Owens MD, PhD
1:30 PM-2:30 PM
AAN Leadership: Using Experiences to Answer the Tough Questions Robert Griggs MD, FAAN, Terrence Cascino MD, FAAN, Stephen Sergay MB BCh, FAAN, Ralph Sacco MD, MS, FAHA, FAAN, Sandra Olson MD, FAAN, Roger Rosenberg MD, FAAN, Stanley Fahn MD, FAAN, Francis Kittredge MD,FAAN
2:00 PM-2:30 PM
SIGN Faculty Advisor Conversation Yolanda Reyes-Iglesias MD
2:00 PM-2:45 PM
Teaching the Next Generation of Physician Advocates: Advocacy Curriculum for Neurology Residents Kara Stavros MD, Jonathan Cahill MD, FAAN
Navigating a Career in Academics Joseph Safdieh MD, FAAN, Jennifer Molano MD, FAAN
2:30 PM-3:15 PM
Introduction to Acupuncture 1 - Conceptual Framework and Mechanism of Action Alexandra Dimitrova MD
3:00 PM-3:45 PM
Practice Innovation in Epilepsy Anup Patel MD, FAAN
Lost in Translation: Acknowledging and Respecting Cultural Differences With Your Patients Jose Merino MD, MPhil, FAAN, Joseph Sirven MD, FAAN
Education Research: The Secret Sauce to Career Advancement as Clinician Educator Andrew Southerland MD
3:30 PM-4:15 PM
S7 - Global Health
3:30 PM-4:45 PM
S8 - Neuro Trauma and Sports Neurology
3:30 PM-5:30 PM
C76 - Assessment of Rapidly Progressive Dementias II: Infections and Autoimmune Mediated Conditions Michael Geschwind MD, PhD, FAAN
C67 - Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology Ralph Jozefowicz MD, FAAN, Adam Quick MD
C68 - Cerebrovascular Disease IV: Telestroke Eric Anderson MD, PhD
C69 - The Palliative Care Guide in Neurology: Best Practice in Communication, Advance Care Planning, and End-of-life Care of Patients with Brain Tumors and Other Life-limiting Neurological Disorders Tobias Walbert MD, PhD
C70 - Introduction to Primary Headache Disorders: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Thunderclap Headaches Christopher Boes MD, FAAN
C72 - Disordered Sleep in Common Neurologic Diseases: Traumatic Brain Injury, Stroke, and Parkinson’s Disease LynnMarie Trotti MD
C73 - Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
C74 - CNS Toxicities Neeraj Kumar MD
C65 - Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia Amanda Peltier MD, MS
N1 - Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN
S9 - Aging and Dementia: Clinical Trials and Novel Therapies
S10 - Biomarkers in Movement Disorders
S11 - Autoimmune CNS Inflammatory Disorders: Clinical Advances
3:45 PM-4:30 PM
Introduction to Acupuncture II - Evidence-based Applications for Acupuncture in the Treatment of Painful Neurologic Conditions Alexandra Dimitrova MD
4:00 PM-4:45 PM
Navigating Prior Authorizations Pearce Korb MD, FAAN
Living an Alpha Brain Wave Life: Work/Life Balance Tamika Burrus MD, FAAN
4:15 PM-5:00 PM
The Teenage Brain: Neuroscience You Can Use Frances Jensen MD, FAAN
4:45 PM-5:30 PM
Neuro-oncology Section Guided Poster Tour
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
How to Be a Teacher as a Resident Jeremy Cutsforth-Gregory MD
5:15 PM-6:15 PM
Standing on the Shoulders of Giants Cynthia Comella MD, FAAN

Monday, May 6, 2019
7:00 AM-7:30 AM
Tips to Sail Through the IRB Deborah Hall MD, PhD, FAAN
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-8:45 AM
Clerkship Administrators Certification Program Celia Linton
7:00 AM-9:00 AM
C77 - Addiction Albert Arias MD
C78 - Young Onset and Atypical Alzheimer's Dementia Jonathan Graff-Radford MD
C79 - Differential Diagnosis of Neurologic Infections Michael Wilson MD, FAAN
C80 - Epileptologists’ Secrets for the Busy General Neurologist: Localization, Imaging, and Fear of Surgery Carol Ulloa MD
C81 - Core Principles of Brain Tumors Nimish Mohile MD, FAAN
C82 - Stroke in Young Adults and Women Aneesh Singhal MD, FAAN
C83 - Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN
C85 - Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD, MPH, FAAN
C86 - Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN
C87 - Skills Workshop: Clinical Usefulness of Botulinum Toxin for Spasticity (Registration Required) Allison Brashear MD, MBA, FAAN
7:30 AM-9:00 AM
Student Interest Group in Neurology (SIGN) Meeting Madhu Soni MD, FAAN
8:00 AM-8:45 AM
Physical Exercise and Cognitive Training in Neurology-Application in Aging & Neurodegenerative Disease Ergun Uc MD
Personal Finances for Residents Brad Klein MD, MBA, FAAN
8:00 AM-9:00 AM
Updating the NIH BRAIN Initiative: A Dialogue with the AAN Walter Koroshetz MD, FAAN
8:30 AM-9:00 AM
Residency Program Director Conversation Rana Said MD, FAAN
9:15 AM-12:00 PM
Contemporary Clinical Issues Plenary Session Randolph Marshall MD, FAAN
11:30 AM-6:30 PM
11:45 AM-12:30 PM
Self-management in Neurologic Disease Lisa Shulman MD, FAAN, Barbara Jobst MD, FAAN
12:00 PM-12:45 PM
Almuerzo con Colegas: Neurología general / investigaciones clínicas
Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars (TRANSCENDS) Program Bruce Ovbiagele MD, MSc, FAAN
LGBTQ+ Health in Neurology - Why It's Important and What You Need to Know Nicole Rosendale MD
12:00 PM-1:00 PM
Would You Fly With This Pilot? Joseph Sirven MD, FAAN
1:00 PM-1:30 PM
Diversity Officer Roundtable Discussion Roy Hamilton MD, MS, FAAN
1:00 PM-1:45 PM
Controversies in Neuroimaging James Johnston MD, JD, FAAN, James Burke MD
1:00 PM-2:00 PM
Advancing Medicine: Inspiration and Innovation Featuring Mona Hanna-Attisha, MD, MPH, FAAP Mona Hanna-Attisha MD, MPH, FAAP
1:00 PM-3:00 PM
C88 - Mild Cognitive Impairment: Implications for Clinicians Ronald Petersen PhD, MD, FAAN
C101 - Clinical EMG I: Principles and Practice of NCS and Needle EMG Ruple Laughlin MD, FAAN
C89 - Tuberculosis of the Central Nervous System Jerome Chin MD, PhD, MPH, FAAN
C90 - Clinical Epilepsy I: Basics Tracey Milligan MD, FAAN
C91 - Neurology Update III: Headache, Neuro-otology, and Epilepsy Ralph Jozefowicz MD, FAAN, Adam Quick MD
C92 - Autism Spectrum Disorders What We Know and Where We Are Going Rujuta Wilson MD
C93 - Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
C95 - Concussion: Topics in Acute Concussion Nicole Reams MD
C97 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know Alison Pack MD
C98 - Faculty Development: Enhancing Your Role in Student and Resident Training Vicki Shanker MD, FAAN
C100 - Esclerosis Múltiple y Otras Enfermedades Inflamatorias Desmielinizantes y Autoinmunes del Sistema Nervioso Central (MS and Other Demyelinating Inflammatory and Autoimmune Central Nervous System Disorders) Lilyana Amezcua MD, FAAN
N2 - Neuroscience in the Clinic: Interpretations of Genetic Results Karen Marder MD, MPH, FAAN, Massimo Pandolfo MD, FAAN
S12 - Progressive Multiple Sclerosis
S13 - Behavioral and Cognitive Neurology: Behavioral Neurology, Aging, and Dementia
S14 - Translational and Clinical Advances in Neuro-oncology
S15 - Intracerebral Hemorrhage and SAH
S16 - Huntington's Disease: From Bench to Clinical Trials
S17 - Headache: Clinical Trials I
1:00 PM-5:30 PM
C103 - Resident Basic Science III: Neuroanatomy: All the Lesions Zachary London MD, FAAN
C105 - Skills Workshop: Clinical Uses of Botulinum Toxin for Dystonia (Registration Required) Diego Torres-Russotto MD, FAAN
C104 - Research Career Symposium Chad Hales MD, PhD, FAAN
1:30 PM-2:30 PM
Blind Spots: The Impact of Conscious and Unconscious Biases Jeffrey McClean MD, FAAN, Charles Flippen MD, FAAN, Laraine Kaminsky
2:00 PM-2:45 PM
Using EHR to Close Referral Loops Melissa Yu MD, FAAN, Allison Weathers MD, FAAN, Allan Wu MD, FAAN
A Career in Clinical Practice Stephen Sergay MB BCh, FAAN
2:00 PM-3:00 PM
ABPN Continuing Certification Information Session J. Clay Goodman MD, FAAN, A. Gordon Smith MD, FAAN
2:30 PM-3:15 PM
The Role of Integrative Medicine in Epilepsy Ann Marie Collier MD
2:45 PM-3:30 PM
Self Reflected: Deeply Fusing Art and Science to Create the World's Most Complex Artistic Depiction of the Human Brain Greg Dunn PhD
3:00 PM-3:45 PM
Research Outputs from the Axon Registry Lyell Jones MD, FAAN
Child Neurology for Trainees Rana Said MD, FAAN
3:30 PM-4:00 PM
Residency Program Director Conversation Emily Pharr MD
3:30 PM-4:45 PM
S18 - Autonomic Disorders
3:30 PM-5:30 PM
C113 - Concussion: Chronic Symptoms -- Selected Considerations for Why Your Patient May Not be Getting Better Michael Jaffee MD, FAAN
C120 - Clinical EMG II: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography Ruple Laughlin MD, FAAN
C106 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment David Knopman MD, FAAN
C107 - Emergency Room Neuro-ophthalmology Heather Moss MD, PhD, FAAN
C108 - Clinical Epilepsy II: Considerations Across the Age Span: Pediatrics, Pregnancy, and Elderly Barbara Jobst MD, FAAN
C109 - Neurology Update IV: Stroke, Neuro-infectious Disease, and Autoimmune Encephalopathies Ralph Jozefowicz MD, FAAN, Adam Quick MD
C110 - Adult and Pediatric Neuro-Oncology for the Neurohospitalist Na Tosha Gatson MD, PhD
C114 - The Global Burden of Neurologic Diseases Cumara O'Carroll MD
C115 - Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease John Hixson MD
C116 - LGBTQI Health in Neurology Holly Hinson MD, MCR, FAAN
C117 - Tourette Syndrome: Assessment and Management Tamara Pringsheim MD, FAAN
C119 - Actualización en lesión cerebral traumática e ictus isquémico (Update: TBI and Stroke) Dario Beltran MD, FAAN, Jose Merino MD, MPhil, FAAN
S19 - Child Neurology: Updates in Autism, Migraine, MS, and Stroke
S20 - Headache Imaging and Physiology and Episodic Syndromes Associated with Migraine
S21 - Autoimmune Neurology: Novel Diagnostic and Predictive Biomarkers and Immunopathologic Mechanisms of Disease
S22 - Stroke Genetics, Cellular Responses, and Animal Models
S23 - Genetic Muscle Disorders
Presentation of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
3:45 PM-4:30 PM
Nutrition, Lifestyle, and Neuropathic Pain Julie Rowin MD, FAAN
3:45 PM-4:45 PM
Philadelphia: The City of Neurology Love Frances Jensen MD, FAAN, Christopher Goetz MD, FAAN, Stephen Reich MD, FAAN, Donald Silberberg MD,FAAN
4:00 PM-4:30 PM
Clerkship Director Conversation Holli Horak MD, FAAN
4:00 PM-4:45 PM
#MeanReviews: Flipping Imposter Syndrome on Its Head Rachel Marie Salas MD, FAAN
4:30 PM-5:00 PM
Everything You Wanted to Know About the Neurology® Resident & Fellow Section John Millichap MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
Residency Program Director Conversation Erica Schuyler MD
Critical Care and Emergency Neurology Section Guided Poster Tour
5:00 PM-5:45 PM
Defining, Evaluating, and Promoting Healthy Cognitive Aging Kirk Daffner MD, FAAN
Careers in Movement Disorders Stanley Fahn MD, FAAN
5:00 PM-6:00 PM
Standing on the Shoulders of Giants Kenneth Heilman MD, FAAN

Tuesday, May 7, 2019
7:00 AM-7:30 AM
Diversifying Your Funding Sources with NIH and Other Sources Ana-Claire Meyer MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Pursuing a Career in Industry Brandy Matthews MD, FAAN
7:00 AM-9:00 AM
C121 - Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Mark Bromberg MD, PhD, FAAN
C123 - Child Neurology: Genetic and Metabolic Testing in Pediatric Epilepsy James Riviello MD
C122 - Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C124 - Endovascular Treatment of Acute Stroke and Cerebrovascular Disease Dileep Yavagal MD, FAAN
C126 - Active Management of Professionalism Lapses: A New Way of Thinking Ann Poncelet MD, FAAN
C127 - Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
C128 - Neck Pain, Cervical Spinal Stenosis, Cervical Radiculopathy, and Cervical Spondylotic Myelopathy John Engstrom MD, FAAN
C129 - Critical Care Consultations for Neurohospitalists Vanja Douglas MD
C130 - Diagnostic Pearls in Myelitis: a Case-based Approach Eoin Flanagan MBBCh
7:30 AM-9:00 AM
C263 - Access: Strategies to Improve Access in Academic Medicine Jaya Trivedi MD, FAAN
8:00 AM-8:45 AM
Welcome to NIH Day/Overview of NIH Funding with NINDS Director and NIA Director, Division of Neuroscience Walter Koroshetz MD, FAAN
9:15 AM-11:30 AM
Clinical Trials Plenary Session Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN
11:30 AM-6:30 PM
P3 - Poster Session 3
11:45 AM-12:45 PM
Emerging Science Session
12:00 PM-12:30 PM
Learn About Opportunities to Work with the NIH Intramural Program Avindra Nath MD, MBBS, FAAN
12:00 PM-12:45 PM
Optimizing Communication in Difficult Patient Relationships Veronica Santini MD, MA
12:00 PM-1:00 PM
Neuro Game Show: Localize the Lesion Luis Torres MD
12:30 PM-1:00 PM
NIH Grant Review Process Shanta Rajaram PhD
1:00 PM-1:45 PM
Virtual Reality for Chronic Pain Mary Catherine George PhD
Women in Neurology: Thriving Through Challenges Kathrin LaFaver MD, FAAN, Divya Singhal MD, FAAN
K Awards and Training Programs – Planning for a Career as an NIH Investigator Nina Schor MD, PhD, FAAN
1:00 PM-2:00 PM
S24 - Lost Connections: From Functional Connectivity to Needs in Pain and Palliative Care
1:00 PM-3:00 PM
C132 - Frontotemporal Dementias Elizabeth Finger MD, FAAN
C131 - Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System Christopher Gibbons MD, FAAN
C133 - Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) William Tatum DO, FAAN
C135 - Case Studies: Challenging Acute Ischemic Stroke Cases Vivien Lee MD, FAAN
C136 - Neuroimaging for the General Neurologist I: Brain Joshua Klein MD, PhD, FANA, FAAN, Ligia Onofrei MD
C137 - Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Michael Pourfar MD
C138 - Hot Topics in Headaches and Related Disorders I: Unusual Headaches, Childhood Headaches, and Concussion Management Amy Gelfand MD
C140 - Sports Neurology: Enhancing Athletic Performance Bert Vargas MD, FAAN
C142 - Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS Stacey Clardy MD, PhD
C143 - Education Research Methodology Course Andrew Southerland MD
N3 - Neuroscience in the Clinic: Stem Cells Paul George MD, PhD, MSE, Antonio Omuro MD
C144 - Actualización científica I (Scientific Update I - Spanish) Edgar Samaniego MD
S25 - Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
S26 - MS and CNS Inflammatory Disease: Clinical Considerations II
S27 - General Neurology: Improving Neurologic Care and the Impact of Therapeutics
C264 - Division Chief's Round Table: Maximizing Effectiveness and Addressing Challenges Claire Henchcliffe MD, PhD, FAAN
1:00 PM-5:30 PM
C148 - Skills Workshop: EMG: Basic (Registration Required) Holli Horak MD, FAAN
1:30 PM-2:30 PM
Neuro Exam Tricks and Tips Ludwig Gutmann MD, FAAN, Nancy Newman MD, FAAN, Laurie Gutmann MD, FAAN
1:45 PM-2:15 PM
NIH Funding and Professional Development Opportunities for Diverse Researchers Michelle Jones-London PhD
2:00 PM-2:45 PM
The HSR Game Show Gregory Esper MD, MBA, FAAN, Jason Sico MD, FAAN
2:15 PM-3:00 PM
Treating Pain with Herbs, Supplements, and Marijuana Ilene Ruhoy MD
Clinical Trials and Networks – NeuroNEXT, StrokeNET, SIREN; Alzheimer’s Clinical Trials Consortium Clinton Wright MD, FAAN
3:00 PM-3:45 PM
Live Intraoperative Monitoring Constantine Moschonas MD, FAAN
Oportunidades de colaboración internacional para realizar proyectos de investigación en enfermedades neurodegenerativas (Opportunities for International Collaborations to Conduct Research on Neurodegenerative Diseases) Yakeel Quiroz PhD
AD/ADRD Opportunities Clinton Wright MD, FAAN
3:30 PM-4:00 PM
Writing and Reviewing for the Neurology® Resident & Fellow Section John Millichap MD, FAAN
3:30 PM-5:30 PM
C150 - Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Christopher Gibbons MD, FAAN
C151 - Lewy Body Dementias Karen Marder MD, MPH, FAAN
C164 - Update on Medical Management of Stroke Adam De Havenon MD
C154 - Neuroimaging for the General Neurologist II: Brain Shamik Bhattacharyya MD, Joshua Klein MD, PhD, FANA, FAAN
C155 - Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders Leonard Verhagen Metman MD, PhD
C156 - Hot Topics in Headaches and Related Disorders II: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances Andrew Charles MD
C157 - Evaluation and Treatment of Common Spine Disorders J. D. Bartleson MD, FAAN
C158 - Sports Concussion: Event Coverage Foundational Skills and Sport Specific Pearls Vernon Williams MD, FAAN
C159 - Mid-Level Faculty Career Development Course Deborah Hall MD, PhD, FAAN
C160 - Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience Eoin Flanagan MBBCh
C161 - Child Neurology: Metabolic Marc Patterson MD, FAAN, FRACP
C152 - Clinical Epilepsy IV: Surgery Gregory Cascino MD, FAAN
C163 - Creating a Roadmap for a Diverse Workforce in Academic Neurology Roy Hamilton MD, MS, FAAN, Nimish Mohile MD, FAAN
C149 - Clinical Neurology for Advanced Practice Providers Jessica Erfan PA-C
S30 - Brain Cancer: From Epidemiology to Quality of Life
S31 - MS and CNS Inflammatory Disease: Imaging
S32 - General Neurology: Advances in Neurology: From the Clinic to the Bench
IS2 - Invited Science: Movement Disorders Deborah Hall MD, PhD, FAAN
Presentation of the Sheila Essey Award: An Award for ALS Research
3:45 PM-4:30 PM
HEAL Initiative - Pain Research Funding Opportunities, Clinical and Basic Michael Oshinsky PhD
4:00 PM-4:45 PM
Healthcare Disparities in Populations Jeffrey McClean MD, FAAN, Brett Kissela MD, FAAN, MS, Alejandro Vargas MD, Sharon Lewis MD
Not Dead Yet: How to Remain Relevant and Engaged in Mid to Late Career Heidi Schwarz MD, FAAN
4:30 PM-5:00 PM
Translational Research Amir Tamiz
Using the Neurology® Resident & Fellow Section John Millichap MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
From Private Practice to Academics Sarah Benish MD, FAAN
5:00 PM-6:00 PM
Standing on the Shoulders of Giants Nancy Newman MD, FAAN

Wednesday, May 8, 2019
7:00 AM-7:30 AM
How to Write and Publish Research Papers, Reviews, and Other Scientific Communication Mark Hallett MD, FAAN
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Simulation in Neurology Education Aaron Nelson MD, Arielle Kurzweil MD, Ariane Lewis MD
7:00 AM-9:00 AM
C165 - Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Robert Brown MD, FAAN
C166 - Neuroimaging Biomarkers Across the Dementia Spectrum Liana Apostolova MD, FAAN
C167 - Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome Ligia Onofrei MD
C168 - Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
C169 - Neurological Intensive Care I: The Essentials David Greer MD, FAAN
C170 - Video EEG: Name That Spell Amy Crepeau MD
C171 - Child Neurology: Neuromuscular/Autoimmune Neurology Anne Connolly MD, FAAN
C172 - Advances in Neurogenetics Matthew Harms MD
C173 - Skills Workshop: Practical Training in Injection Techniques in the Treatment of Headache Disorders (Registration Required) Rashmi Halker Singh MD, FAAN, Amaal Starling MD
8:00 AM-8:30 AM
Recruiting Underrepresented Populations into Trials Temitayo Oyegbile MD, PhD
8:00 AM-8:45 AM
Complementary Therapies in Parkinson's Disease Veronica Santini MD, MA
Consejos prácticos para educadores médicos (Practical Advice for Medical Educators) Yazmin Odia MD, FAAN, MS
8:30 AM-9:00 AM
Neuroscience Course Director Conversation Madhu Soni MD, FAAN
9:15 AM-11:30 AM
Frontiers in Neuroscience Plenary Session Paul George MD, PhD, MSE
11:00 AM-11:30 AM
Resident and Fellow Conversation Abhimanyu Mahajan MD
11:30 AM-6:30 PM
P4 - Poster Session 4
11:45 AM-12:30 PM
Eating Your Way to Fewer Migraines Belinda Savage-Edwards MD, FAAN, Chef Tess Connor
12:00 PM-12:45 PM
Funding Clinically Oriented/Translational Research Before R01 – Consortium and Foundation Opportunities Aasef Shaikh MD
12:00 PM-1:00 PM
Neuro-Jeopardy: Telencephalon Twisters Laurice Yang MD, MHA, Veronica Santini MD, MA
1:00 PM-1:45 PM
Understanding the AAN's Latest Guidelines Tamara Pringsheim MD, FAAN
Headache Neuromodulation Therapy Heidi Schwarz MD, FAAN
Teaching Neurologic Competency Competently Despite the Competencies: A.B. Baker Award for Lifetime Achievement in Neurologic Education Keynote Address Steven Lewis MD, FAAN
1:00 PM-2:00 PM
Advancing Medicine: Inspiration and Innovation Featuring Patricia Churchland, PhD Patricia Churchland PhD
1:00 PM-3:00 PM
C175 - Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia Laura Tormoehlen MD, FAAN
C176 - Behavioral Neurology I: Network Anatomy of Behavior and Language Maria Gorno Tempini MD, PhD
C177 - Maximizing Quality of Life in Stroke, ALS, Parkinson’s Disease, and Dementia: A Palliative Approach Maisha Robinson MD, MS
C178 - Therapy in Neurology I: Neurological Infectious Diseases and Neuro-oncology Madhu Soni MD, FAAN
C179 - Nonmotor Manifestations of Parkinson's Disease I Jennifer Goldman MD, MS, FAAN
C187 - Comprehensive Migraine Update I: Migraine Diagnosis, Pathophysiology, and Comorbidities Gretchen Tietjen MD
C180 - Neurological Intensive Care II: Acute Brain and Spinal Cord Injury and Acute Neuromuscular Dysfunction Kristine O'Phelan MD
C181 - Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN
C182 - Neuroimaging for the General Neurologist: Spine J. D. Bartleson MD, FAAN, Felix Diehn MD
C183 - Reading, Critiquing, and Reviewing the Neurologic Literature: An Evidence-based Approach and Case-based Presentation of Peer Reviews in Neurology Roy Strowd MD
C185 - Actualización en trastornos del movimiento (Update in Movement Disorders) Andres Deik Acosta Madiedo MD
C186 - Women Founders of Neurology and Neuroscience I Stefano Sandrone PhD
N4 - Neuroscience in the Clinic: Immunotherapies in Neurological Disease Holly Hinson MD, MCR, FAAN, John Corboy MD, FAAN
S34 - Aging and Dementia: Risk Factors, Biomarkers, and Neuropathology
S35 - Stroke Prevention Strategies
S36 - Epilepsy/Clinical Neurophysiology (EEG) II
S37 - MS Biomarkers
S38 - Headache: Clinical Trials II
1:00 PM-5:30 PM
C190 - Skills Workshop: Neurostimulation (Registration Required) David Spencer MD, FAAN
C191 - Skills Workshop: Neuromuscular Ultrasound (Registration Required) Craig Zaidman MD
1:30 PM-2:30 PM
The Zoo Called - You Have a Consult Ann Tilton MD, FAAN
2:00 PM-2:30 PM
TALK CANCELLED: A Career in Autoimmune Neurology Pooja Raibagkar MD
3:00 PM-3:45 PM
Foundations in Success in the AAN Christine Phelps , Michael Markowski DO, FAAN, Ann Tilton MD, FAAN, Holly Hinson MD, MCR, FAAN, Jeffrey McClean MD, FAAN, Terrence Cascino MD, FAAN, Orly Avitzur MD, MBA, FAAN
How to Successfully Incorporate APPs into Your Practice James Stevens MD, FAAN
3:30 PM-5:30 PM
C192 - Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission Laura Tormoehlen MD, FAAN
C193 - Behavioral Neurology II: Memory and Attention Maria Gorno Tempini MD, PhD
C195 - Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease Madhu Soni MD, FAAN
C194 - CANCELED Faculty
C196 - Nonmotor Manifestations of Parkinson's Disease II Jennifer Goldman MD, MS, FAAN
C203 - Comprehensive Migraine Update II: Pharmacologic and Non-Pharmacologic Therapies Gretchen Tietjen MD
C197 - Neurological Intensive Care III: Vascular Diseases Lori Shutter MD, FCCM, FNCS
C198 - Integrating Sleep Medicine Concepts into Your Child Neurology Practice Suresh Kotagal MD, FAAN
C199 - Neuroimaging for the General Neurologist: Peripheral Nerve Kimberly Amrami MD, J. D. Bartleson MD, FAAN
C200 - Neurologic Case Studies in Pregnancy Amy Hessler DO, FAAN
C202 - Women Founders of Neurology and Neuroscience II Stefano Sandrone PhD
N5 - Neuroscience in the Clinic: Wearable Technology Deborah Hall MD, PhD, FAAN, Eric Klawiter MD, FAAN
S39 - Education Research and Research Methodology
S40 - Stroke Risk Factors and Epidemiology
S41 - Imaging in Movement Disorders
S43 - Immunotherapies and Drug Trials in Autoimmune Neurological Disorders
S42 - Neuromuscular Disorders
Presentation of the John Dystel Prize for Multiple Sclerosis Research
3:45 PM-4:15 PM
Update on the Complementary Therapies for MS: An Evidence-based Review Vijayshree Yadav MD, FAAN
4:00 PM-4:45 PM
Choosing a Career in Neurocritical Care Katharina Busl MD, MS
4:15 PM-5:00 PM
Is There a Neurologist in the Stands? Glynnis Zieman MD, Javier Cardenas MD
4:45 PM-5:30 PM
Clinical Neurophysiology Section Guided Poster Tour
5:00 PM-5:45 PM
Case Studies: When to Refer Patients for Cognitive Behavioral or Mindfulness-based Psychotherapies: Expanding the Neurologist's Toolkit Gaston Baslet MD, David Perez MD, Aneeta Saxena MD
Perspectivas profesionales para neurólogos en los Estados Unidos y América Latina (Professional Perspectives for Neurologists in the United States and Latin America) Ildefonso Rodriguez-Leyva MD, FAAN, Pedro Gonzalez-Alegre MD
5:15 PM-6:15 PM
Standing on the Shoulders of Giants Vladimir Hachinski MD, DSc, FAAN

Thursday, May 9, 2019
7:00 AM-7:30 AM
So Your Paper Didn’t Get Accepted, Now What? Roy Strowd MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-9:00 AM
C205 - Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies David Herrmann MD, FAAN
C206 - Vascular Cognitive Impairment and Dementia: Current Status and Future Larry Goldstein MD, FAAN, FAHA
C207 - Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD, FAAN
C209 - Movement Disorders for the General Neurologist I: New Concepts in the Diagnosis and Management of Parkinson's Disease Irene Litvan MD, FAAN
C210 - Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management Kathleen Digre MD, FAAN
C212 - Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Wayne Grody MD, PhD
C213 - Communication Skills: From Good to Great Jessica Besbris MD
C214 - Child Neurology: A Case-based Approach Elaine Wirrell MD, FAAN
8:00 AM-8:30 AM
Neuroscience of Bias Jose Posas MD
8:00 AM-8:45 AM
Creating, Evaluating, and Publishing Your Active Learning Modules Diana Barratt MD, MPH, FAAN
A Migraine in Room 3: Patient-centered Care for Residents Paul Schanfield MD
9:15 AM-11:30 AM
Controversies in Neurology Plenary Session Amy Brooks-Kayal MD, FAAN, Aleksandar Videnovic MD, MSc, FAAN
11:30 AM-6:30 PM
P5 - Poster Session 5
11:45 AM-12:30 PM
How Your Social Life Might Be Helping (or Harming) Your Brain Joel Salinas MD
12:00 PM-12:45 PM
A "How to and Why" of the Shared Medical Appointments: A Way to Meet the Needs of the Patient and Provider While Maximizing Clinical Time Nancy Isenberg MD, MPH, FAAN, Mary Rensel MD, FAAN
12:00 PM-1:00 PM
Who Wants to Be a Millionaire Jose Posas MD
1:00 PM-1:45 PM
Acupuncture Demonstration - 4 Gates Jennifer Bickel MD, FAAN
Are You My Mentor? Finding the Right Fit for Success in Research Holly Hinson MD, MCR, FAAN
1:00 PM-2:30 PM
S44 - History of Neurology
Preview Film on Robin Williams’ Journey with LBD with His Wife Susan Schneider Williams
1:00 PM-3:00 PM
C215 - Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies Michelle Mauermann MD, FAAN
C216 - Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
C217 - Core Concepts in Pain Management: Refractory Neuropathic Pain Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids James Watson MD
C218 - Critical Care EEG Monitoring Suzette LaRoche MD, FAAN
C219 - Therapy in Neurology III: Epilepsy and Headache David Dodick MD, FAAN
C220 - Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia Joohi Jimenez Shahed MD
C226 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I Jeffrey Gelfand MD, MAS, FAAN
C221 - Functional Neurologic Disorders I: Movement, Seizures, and Multiple Sclerosis Alberto Espay MD, FAAN
C222 - Good Neurology in Challenging Conditions: Lessons from Military Neurology Michele Gatheridge MD
C223 - United We Stand: Enhancing Your Practice with APPs Jessica Erfan PA-C
C225 - Actualización científica II (Scientific Update II) Alejandro Tobon MD
S47 - Stroke Outcomes and Recurrence
S48 - Epilepsy/Clinical Neurophysiology (EEG) III
S49 - MS Epidemiology and Risk Stratification
1:00 PM-5:30 PM
C227 - Genomic Neurology: Developing Practical Knowledge of Tools and Concepts Through Case Studies Jeffery Vance MD, PhD
C228 - Skills Workshop: Brain Death: How to Perform a Brain Death Evaluation, Avoid Pitfalls and Convey the News to the Family (Registration Required) Panayiotis Varelas MD, PhD, FAAN
1:30 PM-2:30 PM
Rocky's Legacy: Historical Controversies of Boxing-related Concussions Anthony Alessi MD, FAAN, Barry Jordan MD, Tad Seifert MD
2:00 PM-2:45 PM
Innovative Ways to Decrease Wait Times in Your Practice Jason Sico MD, FAAN
3:00 PM-3:45 PM
How to Navigate the Demands of the First Years of Your Academic Career Nicholas Johnson MD, FAAN
3:00 PM-4:00 PM
Consejos prácticos para un buen examen neurológico (Neuro Exam Tips and Tricks) Jose Biller MD, FAAN, FACP, FAHA
3:30 PM-5:30 PM
C229 - Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives Mario Saporta MD, PhD, FAAN
C230 - Disparities in Care Charles Flippen MD, FAAN
C231 - Safe and Appropriate Opioid Prescribing in Neurology Adam Burkey MD
C232 - Women With Epilepsy (WWE): Beyond Seizure Control Anne Van Cott MD, FAAN
C233 - Therapy in Neurology IV: Movement Disorders and Stroke David Dodick MD, FAAN
C234 - Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypies, and Tics Shyamal Mehta MD, PhD
C236 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Jeffrey Gelfand MD, MAS, FAAN
C235 - Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
N6 - Neuroscience in the Clinic: The Brain Across the Menstrual Cycle Riley Bove MD, Temitayo Oyegbile MD, PhD
S51 - Child Neurology: Bench to Bedside: Progress in Treating Genetic Disorders
S52 - Acute Non-Interventional Stroke Care
S53 - Movement Disorders: Genetics and Clinical Features
S54 - Motor Neuron Disease
S55 - MS Basic Science
IS3 - Invited Science: Aging and Dementia Karen Marder MD, MPH, FAAN, Heather Snyder PhD
4:00 PM-4:30 PM
Resident and Fellow Conversation Christopher Perrone MD
4:00 PM-4:45 PM
Neurohospitalist Models of Care in an Academic Department: Opportunities and Challenges S. Josephson MD, FAAN
4:30 PM-5:30 PM
Standing on the Shoulders of Giants Stanley Fahn MD, FAAN
5:00 PM-5:30 PM
Division Chief Conversation Amy Brooks-Kayal MD, FAAN
5:00 PM-5:45 PM
Influence of a Comprehensive Lifestyle Intervention on Prevention of Dementia Dean Sherzai MD, MAS, PhD, Ayesha Sherzai MD
Global Neurology: A Work in Progress Jerome Chin MD, PhD, MPH, FAAN
5:30 PM-6:00 PM
Division Chief Conversation Brenda Banwell MD, FAAN
7:00 PM-10:00 PM
C237 - Case Studies: Diagnosis and Management of Unusual Cases in Neuromuscular Disease Robert Pascuzzi MD, FAAN
C238 - Case Studies in the ICU Katharina Busl MD, MS
C239 - Case Studies: Test Your Knowledge: A Case-based Approach to Neuroimaging Joshua Klein MD, PhD, FANA, FAAN
C240 - Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN
C241 - Case Studies: Challenging Headache Cases Kathleen Digre MD, FAAN
C242 - Case Studies: Dementia Gregory Day MD, MSc

Friday, May 10, 2019
7:00 AM-7:30 AM
Grant Writing 101: Getting Started Logan Schneider MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-9:00 AM
C243 - Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Michael Weiss MD, FAAN
C244 - Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases Matthew Hoerth MD
C245 - Controversies in Stroke Treatment and Prevention Pierre Fayad MD, FAAN, FAHA
C246 - Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
C247 - What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders Stephanie Nahas MD, FAAN
C248 - Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
C249 - Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems S. Josephson MD, FAAN
8:00 AM-8:30 AM
How to Put Together Effective Research Presentations Enrique Leira MD, MS, FAAN
8:00 AM-8:45 AM
How to Give Effective Feedback Diana Barratt MD, MPH, FAAN, Adnan Subei DO, Farah Fourcand MD
9:15 AM-11:30 AM
Neurology Year in Review Plenary Session Martinson Arnan MD
11:30 AM-1:00 PM
P6 - Poster Session 6
11:45 AM-12:45 PM
Friday Grand Finale: Neuroimaging
12:00 PM-1:00 PM
The Neurology of Creativity at the Keyboard Phillip Pearl MD, FAAN
1:00 PM-1:45 PM
Growing Research in Medical Marijuana Anup Patel MD, FAAN
K is for Career Development: Tips on Successful Applications for NIH Career Development Awards Logan Schneider MD
1:00 PM-3:00 PM
C250 - Update in Epilepsy Joseph Sirven MD, FAAN
C252 - Update in Aging and Dementia Gil Rabinovici MD
C253 - Update in Movement Disorders Alfonso Fasano MD, PhD
S56 - MS Trials and Treatment
S57 - Acute Treatment and Imaging of Ischemic Stroke
S58 - Therapeutics in Neuromuscular Disorders
S59 - Migraine: Impact, Treatment Patterns and Resource Utilization
1:30 PM-2:15 PM
Movement Disorder Case Studies: What I Have Learned from My Patients Deborah Hall MD, PhD, FAAN, Susan Fox MD, FAAN
2:00 PM-2:30 PM
Choosing a Career in Neuro-oncology Sylvia Kurz MD, PhD
2:00 PM-2:45 PM
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1 Nicholas Johnson MD, FAAN
Consensus-Based Care Recommendations for Adults with haha
2:45 PM-3:30 PM
Neuroanatomy of the Zombie Brain: A Year in Review Brian Hanrahan MD
3:00 PM-3:45 PM
Sleep: Why You Should Spend Your Career Helping People Do It Right Logan Schneider MD
3:30 PM-4:30 PM
C254 - Education Blitz: Child Neurology: Concussion Meeryo Choe MD
C255 - Education Blitz: Normal Pressure Hydrocephalus Neill Graff-Radford MD, FAAN
C257 - Education Blitz: Evolution of Autoimmune Neurology Steven Vernino MD, PhD, FAAN
C258 - Education Blitz: Multiple Sclerosis Stephen Krieger MD, FAAN
4:30 PM-5:30 PM
NeuroZone Bert Vargas MD, FAAN, Mark Milstein MD, FAAN, Jennifer Bickel MD, FAAN, Wayne Anderson MD, FAAN

Universal Navigation

P2 - Poster Session 2

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Footer